(365802, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365803, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365804, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365805, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365806, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365807, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365808, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365809, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365810, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365811, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365812, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365813, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365814, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365815, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365816, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365817, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365818, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365819, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365820, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0003767', 'palate inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365821, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365822, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365823, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004510', 'myositis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365824, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365825, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365826, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365827, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365828, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365829, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365830, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365831, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365832, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365833, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365834, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365835, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365836, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365837, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365838, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365839, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365840, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365841, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365842, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365843, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365844, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365845, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0006082', 'CNS inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365846, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365847, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365848, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365849, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365850, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365851, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365852, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365853, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365854, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0031092', 'dysgeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365855, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365856, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365857, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365858, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365859, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365860, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001861', 'lung inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365861, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365862, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0010994', 'aerophagia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365863, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365864, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365865, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365866, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365867, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365868, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365869, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365870, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365871, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365872, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0010822', 'pneumothorax', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365873, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365874, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365875, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365876, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365877, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365878, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365879, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365880, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0000313', 'abnormal cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365881, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365882, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365883, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365884, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365885, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365886, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365887, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365888, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365889, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365890, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365891, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365892, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365893, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365894, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365895, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0013806', 'encephalopathy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365896, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365897, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001664', 'abnormal digestion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365898, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365899, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365900, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365901, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365902, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365903, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365904, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008544', 'impaired olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365905, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365906, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365907, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365908, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365909, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365910, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0009046', 'muscle twitch', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365911, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365912, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365913, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365914, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0031102', 'rhinorrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365915, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365916, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365917, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365918, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0031091', 'hypogeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365919, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365920, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001873', 'stomach inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365921, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365922, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365923, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365924, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365925, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365926, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365927, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0031110', 'meningitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365928, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0030129', 'tongue inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365929, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365930, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0012565', 'perivasculitis', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365931, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365932, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365933, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365934, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365935, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365936, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365937, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365938, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365939, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365940, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365941, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365942, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365943, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365944, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365945, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365946, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365947, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365948, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365949, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365950, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365951, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365952, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365953, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365954, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365955, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365956, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365957, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365958, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365959, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365960, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365961, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365962, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365963, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0031088', 'coughing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365964, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365965, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365966, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365967, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365968, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365969, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365970, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365971, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365972, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365973, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0030990', 'nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365974, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365975, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365976, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365977, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365978, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365979, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365980, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365981, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004558', 'delayed allantois development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365982, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365983, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365984, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365985, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365986, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365987, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365988, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365989, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365990, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365991, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365992, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365993, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(365994, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365995, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365996, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365997, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365998, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(365999, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366000, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366001, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366002, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366003, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366004, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001844', 'autoimmune response', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366005, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366006, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366007, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366008, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366009, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366010, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366011, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366012, 'HP:0034119', 'Anti-GD1a IgG antibody positivity', 'MP:0004512', 'anosmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366013, 'HP:0025110', 'Placoid macular lesion', 'MP:0006186', 'retina fibrosis', 0.421875, 9.356059413574362, 1.9867278538092943, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(366014, 'HP:0025110', 'Placoid macular lesion', 'MP:0006188', 'calcified retina', 0.417910447761194, 9.356059413574362, 1.9773707236649367, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(366015, 'HP:0025110', 'Placoid macular lesion', 'MP:0020038', 'retina macular degeneration', 0.4117647058823529, 12.083585311854263, 2.230603943316695, 'UPHENO:0076777', 'abnormal macula lutea morphology'),
(366016, 'HP:0025110', 'Placoid macular lesion', 'MP:0020442', 'serous retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(366017, 'HP:0025110', 'Placoid macular lesion', 'MP:0003099', 'retina detachment', 0.4090909090909091, 9.356059413574362, 1.9563943495644465, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(366018, 'HP:0025110', 'Placoid macular lesion', 'MP:0001329', 'retina hyperplasia', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(366019, 'HP:0025110', 'Placoid macular lesion', 'MP:0020441', 'rhegmatogenous retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(366020, 'HP:0025110', 'Placoid macular lesion', 'MP:0001326', 'retina degeneration', 0.4153846153846154, 9.356059413574362, 1.9713860963857883, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(366021, 'HP:0025110', 'Placoid macular lesion', 'MP:0020443', 'tractional retina detachment', 0.40298507462686567, 9.356059413574362, 1.94173950389661, 'UPHENO:0088038', 'abnormal ocular fundus morphology'),
(366022, 'HP:0031889', 'Abnormal VLDL cholesterol concentration', 'MP:0001548', 'hyperlipidemia', 0.425, 9.93472192593978, 2.05481308603104, 'UPHENO:0051628', 'abnormal blood lipid level'),
(366023, 'HP:0031889', 'Abnormal VLDL cholesterol concentration', 'MP:0003949', 'abnormal circulating lipid level', 0.4358974358974359, 9.93472192593978, 2.0809901042223116, 'UPHENO:0051628', 'abnormal blood lipid level'),
(366024, 'HP:0031889', 'Abnormal VLDL cholesterol concentration', 'MP:0031206', 'hypolipidemia', 0.425, 9.93472192593978, 2.05481308603104, 'UPHENO:0051628', 'abnormal blood lipid level'),
(366025, 'HP:0034833', 'Cardiac lipoma', 'MP:0020130', 'abnormal total fat pad weight', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366026, 'HP:0034833', 'Cardiac lipoma', 'MP:0005459', 'decreased percent body fat/body weight', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366027, 'HP:0034833', 'Cardiac lipoma', 'MP:0020520', 'whitened brown adipose tissue morphology', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366028, 'HP:0034833', 'Cardiac lipoma', 'MP:0005458', 'increased percent body fat/body weight', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366029, 'HP:0034833', 'Cardiac lipoma', 'MP:0005334', 'abnormal fat pad morphology', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366030, 'HP:0034833', 'Cardiac lipoma', 'MP:0002970', 'abnormal white adipose tissue morphology', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366031, 'HP:0034833', 'Cardiac lipoma', 'MP:0002971', 'abnormal brown adipose tissue morphology', 0.42857142857142855, 10.226325483970346, 2.0934925177085244, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366032, 'HP:0034833', 'Cardiac lipoma', 'MP:0011174', 'lipodystrophy', 0.4444444444444444, 10.226325483970346, 2.1319084287162204, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366033, 'HP:0034833', 'Cardiac lipoma', 'MP:0020521', 'browned white adipose tissue morphology', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366034, 'HP:0034833', 'Cardiac lipoma', 'MP:0005457', 'abnormal percent body fat/body weight', 0.4444444444444444, 10.226325483970346, 2.1319084287162204, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366035, 'HP:0034833', 'Cardiac lipoma', 'MP:0012320', 'abnormal body fat mass', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366036, 'HP:0034833', 'Cardiac lipoma', 'MP:0000003', 'abnormal adipose tissue morphology', 0.46153846153846156, 10.226325483970346, 2.172519857461201, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366037, 'HP:0034833', 'Cardiac lipoma', 'MP:0013801', 'abnormal subscapular fat pad morphology', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366038, 'HP:0034833', 'Cardiac lipoma', 'MP:0011167', 'abnormal adipose tissue development', 0.4444444444444444, 10.226325483970346, 2.1319084287162204, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366039, 'HP:0034833', 'Cardiac lipoma', 'MP:0013800', 'abnormal pericardial fat pad morphology', 0.41379310344827586, 10.226325483970346, 2.0570811745977067, 'UPHENO:0076797', 'abnormal adipose tissue morphology'),
(366040, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366041, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366042, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366043, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366044, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366045, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366046, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0005076', 'abnormal cell differentiation', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366047, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366048, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366049, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366050, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366051, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366052, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366053, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366054, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366055, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366056, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366057, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366058, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366059, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0000350', 'abnormal cell proliferation', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366060, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366061, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366062, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366063, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366064, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366065, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366066, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366067, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366068, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0003186', 'abnormal redox activity', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366069, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0000313', 'abnormal cell death', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366070, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366071, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366072, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(366073, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0000358', 'abnormal cell morphology', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(366074, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0020846', 'abnormal cell motility', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366075, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366076, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366077, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366078, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0005621', 'abnormal cell physiology', 0.43478260869565216, 4.8755453832354885, 1.4559540997356917, 'UPHENO:0086172', 'abnormal cell'),
(366079, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366080, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366081, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366082, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366083, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366084, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366085, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366086, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0003077', 'abnormal cell cycle', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366087, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366088, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0003566', 'abnormal cell adhesion', 0.4166666666666667, 4.8755453832354885, 1.4252990012677296, 'UPHENO:0086172', 'abnormal cell'),
(366089, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366090, 'HP:0003204', 'Intracellular accumulation of autofluorescent lipopigment storage material', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(366091, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0011294', 'renal glomerulus hypertrophy', 0.4107142857142857, 9.804092483287297, 2.006659124353247, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366092, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0020518', 'renal glomerular protein deposits', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366093, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0011483', 'renal glomerular synechia', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366094, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366095, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0011567', 'increased renal glomerulus lobularity', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366096, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0021199', 'abnormal susceptibility to glomerulonephritis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366097, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.42592592592592593, 9.804092483287297, 2.0434816291827906, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366098, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0011377', 'renal glomerulus fibrosis', 0.4339622641509434, 9.804092483287297, 2.0626696710798362, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366099, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0011561', 'renal glomerulus lipidosis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366100, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0000523', 'cortical renal glomerulopathies', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366101, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0011855', 'abnormal glomerular filtration barrier morphology', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366102, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.40425531914893614, 9.692263881549227, 1.9794315418097665, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(366103, 'HP:0033496', 'Perihilar segmental glomerulosclerosis', 'MP:0011506', 'glomerular crescent', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(366104, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366105, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366106, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010516', 'absent Q wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366107, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010506', 'prolonged RR interval', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366108, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366109, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031128', 'cardiovascular shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366110, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366111, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011951', 'increased cardiac stroke volume', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366112, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0013134', 'poor circulation in autopods', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366113, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366114, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0012046', 'decreased susceptibility to hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366115, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003901', 'abnormal PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366116, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004486', 'decreased response of heart to induced stress', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366117, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366118, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366119, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366120, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004217', 'salt-sensitive hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366121, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006049', 'semilunar valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366122, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366123, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003038', 'decreased myocardial infarct size', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366124, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366125, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011929', 'abnormal aortic valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366126, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366127, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002952', 'ventricular cardiomyopathy', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366128, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366129, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366130, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004085', 'abnormal heartbeat', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366131, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003633', 'abnormal nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366132, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010510', 'absent P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366133, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366134, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366135, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366136, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003882', 'abnormal pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366137, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366138, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031130', 'right-to-left shunt', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366139, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366140, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006265', 'increased pulse pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366141, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366142, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0008776', 'increased right ventricle peak pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366143, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366144, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006048', 'pulmonary valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366145, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366146, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004216', 'salt-resistant hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366147, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366148, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003897', 'abnormal ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366149, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366150, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006266', 'decreased pulse pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366151, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011952', 'decreased cardiac stroke volume', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366152, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366153, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366154, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004156', 'abnormal QT variability', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366155, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006044', 'tricuspid valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366156, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366157, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004071', 'prolonged P wave', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366158, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011928', 'abnormal mitral valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366159, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366160, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366161, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010393', 'shortened QRS complex duration', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366162, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366163, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366164, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366165, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003393', 'decreased cardiac output', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366166, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0005435', 'hemoperitoneum', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366167, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010505', 'abnormal T wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366168, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010520', 'sinoatrial block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366169, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366170, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004013', 'decreased pulmonary artery pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366171, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011931', 'abnormal pulmonary valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366172, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003898', 'abnormal QRS complex', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366173, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366174, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366175, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0013135', 'poor circulation in tail', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366176, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006045', 'mitral valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366177, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366178, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010394', 'decreased QRS amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366179, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0000233', 'abnormal blood flow velocity', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366180, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006046', 'atrioventricular valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366181, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0008950', 'ventricular tachycardia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366182, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031192', 'coronary artery spasm', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366183, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004011', 'decreased diastolic filling velocity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366184, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366185, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366186, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004878', 'increased systemic vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366187, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366188, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366189, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010514', 'fragmented QRS complex', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366190, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003394', 'increased cardiac output', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366191, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006138', 'congestive heart failure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366192, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003438', 'abnormal carotid body physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366193, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366194, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011919', 'abnormal R wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366195, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010519', 'atrioventricular block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366196, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366197, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003233', 'prolonged QT interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366198, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366199, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010392', 'prolonged QRS complex duration', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366200, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020097', 'low mean heart rate adaptation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366201, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366202, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366203, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366204, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002842', 'increased systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366205, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366206, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366207, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004485', 'increased response of heart to induced stress', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366208, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001633', 'poor circulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366209, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011918', 'abnormal PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366210, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011920', 'abnormal S wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366211, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011936', 'abnormal PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366212, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010636', 'bundle branch block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366213, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010756', 'decreased right ventricle peak pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366214, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366215, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011927', 'abnormal cardiac valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366216, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011930', 'abnormal tricuspid valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366217, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366218, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031152', 'subcutaneous hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366219, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002626', 'increased heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366220, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010553', 'prolonged HV interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366221, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010512', 'absent PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366222, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010554', 'shortened HV interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366223, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010507', 'shortened RR interval', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366224, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366225, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366226, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366227, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366228, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366229, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366230, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031170', 'abnormal vasculature physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366231, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0000231', 'hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366232, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031129', 'left-to-right shunt', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366233, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003034', 'increased pulmonary vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366234, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366235, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001914', 'hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366236, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011953', 'prolonged PQ interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366237, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0009698', 'heart hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366238, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366239, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0005333', 'decreased heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366240, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010560', 'intraventricular block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366241, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010515', 'abnormal Q wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366242, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366243, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0008817', 'hematoma', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366244, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004484', 'abnormal response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366245, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003929', 'decreased heart rate variability', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366246, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366247, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003896', 'prolonged PR interval', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366248, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010552', 'abnormal HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366249, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002128', 'abnormal blood circulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366250, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0009732', 'ventricular premature beat', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366251, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003899', 'abnormal QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366252, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366253, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001627', 'abnormal cardiac output', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366254, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010637', 'sinus bradycardia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366255, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010509', 'decreased P wave amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366256, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003037', 'increased myocardial infarct size', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366257, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366258, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011926', 'abnormal heart valve physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366259, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366260, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366261, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010695', 'abnormal blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366262, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366263, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0005532', 'abnormal vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366264, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001634', 'internal hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366265, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0000249', 'abnormal blood vessel physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366266, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366267, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006047', 'aortic valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366268, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366269, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004879', 'decreased systemic vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366270, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006114', 'cardiac murmur', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366271, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366272, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003547', 'abnormal pulmonary pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366273, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366274, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366275, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001629', 'abnormal heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366276, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003039', 'increased time of peak ischemic contracture', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366277, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0012045', 'increased susceptibility to hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366278, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010504', 'abnormal RR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366279, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001636', 'irregular heartbeat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366280, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366281, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366282, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366283, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366284, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004012', 'increased pulmonary artery pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366285, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011938', 'prolonged PP interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366286, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366287, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020096', 'high mean heart rate adaptation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366288, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031302', 'syncope', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366289, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0005330', 'cardiomyopathy', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366290, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366291, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366292, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010571', 'shortened ST segment', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366293, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0009275', 'bruising', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366294, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004010', 'increased diastolic filling velocity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366295, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010513', 'abnormal ventricular activation time', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366296, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366297, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001599', 'abnormal blood volume', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366298, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004070', 'abnormal P wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366299, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366300, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001596', 'hypotension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366301, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010634', 'increased QRS amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366302, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004072', 'abnormal frontal plane axis', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366303, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003823', 'increased left ventricle developed pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366304, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366305, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010511', 'shortened PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366306, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010570', 'prolonged ST segment', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366307, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366308, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003900', 'shortened QT interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366309, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366310, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366311, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0003928', 'increased heart rate variability', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366312, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0001598', 'abnormal blood viscosity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366313, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366314, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0009384', 'cardiac valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366315, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011954', 'shortened PQ interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366316, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0011937', 'shortened PP interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366317, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0020345', 'abnormal myocardial fiber currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366318, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366319, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010559', 'heart block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366320, 'HP:0031672', 'Reverse typical atrial flutter', 'MP:0010631', 'increased Q wave amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(366321, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012204', 'abnormal neuronal stem cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366322, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008556', 'abnormal tumor necrosis factor secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366323, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005671', 'abnormal response to transplant', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366324, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020846', 'abnormal cell motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366325, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001849', 'ear inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366326, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001841', 'decreased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366327, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011951', 'increased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366328, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366329, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010382', 'abnormal dosage compensation, by inactivation of X chromosome', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366330, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011699', 'abnormal brown adipose tissue thermogenesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366331, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002409', 'decreased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366332, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366333, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009643', 'abnormal urine homeostasis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366334, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013561', 'abnormal endocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366335, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0014048', 'abnormal Peyers patch physiology', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366336, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003454', 'erythroderma', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366337, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030214', 'muscle fasciculation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366338, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005005', 'abnormal self tolerance', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366339, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031009', 'abnormal sperm-egg fusion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366340, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013134', 'poor circulation in autopods', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366341, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031102', 'rhinorrhea', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366342, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008559', 'abnormal interferon-gamma secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366343, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005253', 'abnormal eye physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366344, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009732', 'ventricular premature beat', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366345, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003880', 'abnormal central pattern generator function', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366346, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008859', 'abnormal hair cycle catagen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366347, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366348, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001950', 'abnormal respiratory sounds', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366349, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008004', 'abnormal stomach pH', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366350, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005026', 'decreased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366351, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011012', 'bronchiectasis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366352, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005620', 'abnormal muscle contractility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366353, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008942', 'abnormal induced cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366354, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020183', 'abnormal susceptibility to fungal infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366355, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366356, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020930', 'abnormal susceptibility to Adenoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366357, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008661', 'decreased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366358, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003659', 'abnormal lymph circulation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366359, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011518', 'abnormal cell chemotaxis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366360, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011764', 'ureteritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366361, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001633', 'poor circulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366362, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012553', 'decreased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366363, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366364, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011043', 'abnormal lung elastance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366365, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013806', 'encephalopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366366, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008713', 'abnormal cytokine level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366367, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003474', 'abnormal summary potential intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366368, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008651', 'increased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366369, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020913', 'increased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366370, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002869', 'increased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366371, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020001', 'decreased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366372, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004752', 'decreased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366373, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008567', 'decreased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366374, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004210', 'abnormal bitter taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366375, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031130', 'right-to-left shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366376, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020922', 'increased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366377, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003866', 'abnormal defecation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366378, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010223', 'abnormal immunoglobulin transcytosis', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366379, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366380, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004829', 'increased anti-chromatin antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366381, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366382, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366383, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366384, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031054', 'bronchiolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366385, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008658', 'decreased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366386, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002998', 'abnormal bone remodeling', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366387, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008705', 'increased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366388, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004945', 'abnormal bone resorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366389, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004781', 'abnormal surfactant composition', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366390, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012120', 'trophectoderm cell degeneration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366391, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008700', 'decreased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366392, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005614', 'decreased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366393, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003547', 'abnormal pulmonary pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366394, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366395, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008655', 'decreased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366396, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001864', 'vascular inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366397, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002500', 'granulomatous inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366398, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001664', 'abnormal digestion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366399, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003820', 'increased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366400, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002148', 'abnormal hypersensitivity reaction', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366401, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366402, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003463', 'abnormal single cell response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366403, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008563', 'decreased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366404, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020936', 'abnormal susceptibility to Picornaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366405, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000304', 'abnormal cardiac stroke volume', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366406, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011919', 'abnormal R wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366407, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366408, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010922', 'alveolitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366409, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003470', 'abnormal summary potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366410, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013636', 'abnormal bone stiffness', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366411, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004072', 'abnormal frontal plane axis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366412, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031242', 'increased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366413, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003123', 'paternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366414, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009760', 'abnormal mitotic spindle morphology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366415, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0014030', 'abnormal mucous gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366416, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006114', 'cardiac murmur', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366417, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020923', 'decreased susceptibility to Parvoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366418, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030153', 'dental pulp inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366419, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005597', 'decreased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366420, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366421, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012197', 'impaired myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366422, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008672', 'increased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366423, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020002', 'increased response to antigen', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366424, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020371', 'abnormal glymphatic system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366425, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000738', 'impaired muscle contractility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366426, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003077', 'abnormal cell cycle', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366427, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012573', 'decreased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366428, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009058', 'decreased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366429, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010560', 'intraventricular block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366430, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001847', 'brain inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366431, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012207', 'decreased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366432, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020939', 'abnormal susceptibility to Togaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366433, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001873', 'stomach inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366434, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008006', 'increased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366435, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020938', 'decreased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366436, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001627', 'abnormal cardiac output', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366437, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020931', 'increased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366438, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002338', 'abnormal pulmonary ventilation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366439, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010072', 'increased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366440, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005621', 'abnormal cell physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366441, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003261', 'hematemesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366442, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003621', 'dysuria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366443, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004010', 'increased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366444, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013644', 'increased vertebra maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366445, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004036', 'abnormal muscle relaxation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366446, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008744', 'abnormal B cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366447, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020096', 'high mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366448, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366449, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020941', 'decreased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366450, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006003', 'abnormal large intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366451, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005027', 'increased susceptibility to parasitic infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366452, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002296', 'aspiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366453, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002133', 'abnormal respiratory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366454, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005402', 'abnormal action potential', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366455, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003477', 'abnormal nerve fiber response', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366456, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020040', 'decreased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366457, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002499', 'chronic inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366458, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011926', 'abnormal heart valve physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366459, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011082', 'abnormal gastrointestinal motility', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366460, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002841', 'impaired skeletal muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366461, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020927', 'abnormal susceptibility to Poxviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366462, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031090', 'ageusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366463, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008660', 'increased interleukin-10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366464, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002472', 'impaired complement alternative pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366465, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002161', 'abnormal fertility/fecundity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366466, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001839', 'abnormal level of surface class I molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366467, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008696', 'increased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366468, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011716', 'abnormal interleukin-8 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366469, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031089', 'sneezing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366470, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003762', 'abnormal immune organ physiology', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366471, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012006', 'abnormal hippocampus physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366472, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366473, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0014275', 'increased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366474, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005351', 'decreased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366475, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002333', 'abnormal lung compliance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366476, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001793', 'abnormal susceptibility to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366477, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005036', 'diarrhea', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366478, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011045', 'decreased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366479, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031129', 'left-to-right shunt', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366480, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008568', 'abnormal interleukin secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366481, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002410', 'decreased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366482, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004484', 'abnormal response of heart to induced stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366483, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366484, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011804', 'increased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366485, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008694', 'decreased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366486, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011013', 'bronchiolectasis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366487, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003882', 'abnormal pulse pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366488, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008566', 'increased interferon-gamma secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366489, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001756', 'abnormal urination', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366490, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030822', 'sacroiliac joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366491, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012705', 'increased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366492, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004823', 'increased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366493, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005670', 'abnormal white adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366494, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011925', 'abnormal heart echocardiography feature', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366495, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030949', 'abnormal Golgi vesicle transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366496, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008752', 'abnormal tumor necrosis factor level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366497, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030951', 'abnormal endocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366498, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001533', 'abnormal skeleton physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366499, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001876', 'decreased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366500, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005645', 'abnormal hypothalamus physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366501, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020845', 'abnormal DNA-templated transcription', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366502, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004794', 'increased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366503, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020914', 'decreased susceptibility to Riboviria infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366504, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002694', 'abnormal pancreas secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366505, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008682', 'decreased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366506, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001636', 'irregular heartbeat', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366507, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366508, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008685', 'decreased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366509, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010368', 'abnormal lymphatic system physiology', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366510, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001194', 'dermatitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366511, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010753', 'improved mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366512, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005004', 'abnormal lymphocyte anergy', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366513, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005364', 'increased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366514, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009697', 'abnormal copulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366515, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005403', 'abnormal nerve conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366516, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020925', 'increased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366517, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002498', 'abnormal acute inflammation', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366518, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000423', 'delayed hair regrowth', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366519, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366520, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013641', 'increased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366521, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020945', 'abnormal susceptibility to Orthomyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366522, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013942', 'enthesitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366523, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005666', 'abnormal adipose tissue physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366524, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010994', 'aerophagia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366525, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008668', 'abnormal interleukin-12b secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366526, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366527, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031014', 'polyspermy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366528, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020934', 'increased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366529, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003899', 'abnormal QT interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366530, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366531, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004782', 'abnormal surfactant physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366532, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011936', 'abnormal PP interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366533, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0021021', 'abnormal adipose tissue noradrenaline turnover', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366534, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001983', 'abnormal olfactory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366535, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011566', 'abnormal complement protein level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366536, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366537, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008005', 'decreased stomach pH', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366538, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001911', 'abnormal cerebrospinal fluid production', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366539, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020162', 'decreased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366540, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005399', 'increased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366541, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013625', 'increased femur yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366542, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013289', 'abnormal mitotic cytokinesis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366543, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030216', 'tongue muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366544, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031098', 'abnormal sputum production', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366545, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030215', 'facial muscle fasciculation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366546, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004142', 'abnormal muscle tone', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366547, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002533', 'abnormal type III hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366548, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366549, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031402', 'decreased muscle fatigability', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366550, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020929', 'decreased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366551, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013557', 'abnormal merocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366552, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031169', 'abnormal joint physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366553, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000505', 'decreased digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366554, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003157', 'impaired muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366555, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031013', 'abnormal egg activation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366556, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010538', 'increased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366557, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004209', 'abnormal sweet taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366558, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011698', 'abnormal brown adipose tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366559, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004802', 'decreased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366560, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003777', 'lip inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366561, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001835', 'abnormal antigen presentation', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366562, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366563, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004212', 'abnormal salty taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366564, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008704', 'abnormal interleukin-6 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366565, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002578', 'impaired ability to fire action potentials', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366566, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005580', 'periinsulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366567, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002330', 'abnormal bronchial provocation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366568, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008748', 'abnormal central T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366569, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008687', 'increased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366570, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011920', 'abnormal S wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366571, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004761', 'increased susceptibility to induced pancreatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366572, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001861', 'lung inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366573, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005000', 'abnormal immune tolerance', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366574, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001840', 'increased level of surface class I molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366575, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031105', 'rhonchi', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366576, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008697', 'decreased interleukin-3 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366577, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003865', 'lymph node inflammation', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366578, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003926', 'decreased cellular glucose uptake', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366579, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012206', 'increased neuronal stem cell self-renewal', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366580, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001629', 'abnormal heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366581, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0021015', 'increased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366582, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001985', 'abnormal gustatory system physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366583, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009878', 'decreased susceptibility to bone fracture', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366584, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013642', 'decreased vertebra stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366585, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366586, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002693', 'abnormal pancreas physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366587, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020915', 'abnormal susceptibility to Herpesvirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366588, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013498', 'trachea inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366589, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005043', 'defective assembly of class II molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366590, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004994', 'abnormal brain wave pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366591, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004780', 'abnormal surfactant secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366592, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020912', 'abnormal susceptibility to Riboviria infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366593, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031223', 'increased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366594, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031222', 'decreased CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366595, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020950', 'decreased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366596, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012382', 'abnormal blood cell physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366597, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003260', 'vomiting', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366598, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366599, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366600, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000316', 'cellular necrosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366601, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010377', 'abnormal gut flora balance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366602, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003878', 'abnormal ear physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366603, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030130', 'gum inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366604, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003122', 'maternal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366605, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005087', 'decreased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366606, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001850', 'increased susceptibility to otitis media', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366607, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005190', 'osteomyelitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366608, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003292', 'melena', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366609, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366610, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366611, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011927', 'abnormal cardiac valve flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366612, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031240', 'abnormal CSF3 level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366613, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020951', 'abnormal susceptibility to Paramyxoviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366614, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008557', 'abnormal interferon-alpha secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366615, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002406', 'increased susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366616, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008272', 'abnormal endochondral bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366617, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005041', 'abnormal antigen presentation via MHC class II', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366618, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020942', 'abnormal susceptibility to Flaviviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366619, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003925', 'abnormal cellular glucose uptake', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366620, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008681', 'increased interleukin-17 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366621, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366622, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031095', 'pharyngitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366623, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005612', 'decreased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366624, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012572', 'increased susceptibility to chemically induced skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366625, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005596', 'increased susceptibility to type I hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366626, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006138', 'congestive heart failure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366627, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011432', 'decreased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366628, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008691', 'decreased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366629, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003746', 'stomatitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366630, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005275', 'abnormal skin tensile strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366631, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013459', 'perioral dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366632, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001919', 'abnormal reproductive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366633, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008706', 'decreased interleukin-6 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366634, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005001', 'abnormal clonal deletion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366635, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008722', 'abnormal chemokine secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366636, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002532', 'abnormal type II hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366637, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002405', 'respiratory system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366638, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020039', 'increased bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366639, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000352', 'decreased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366640, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003009', 'abnormal cytokine secretion', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366641, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009567', 'mitotic nondisjunction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366642, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011044', 'increased lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366643, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010552', 'abnormal HV interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366644, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002635', 'reduced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366645, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002418', 'increased susceptibility to viral infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366646, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366647, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003280', 'urinary incontinence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366648, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002064', 'seizures', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366649, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008665', 'abnormal interleukin-12a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366650, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003633', 'abnormal nervous system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366651, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003868', 'abnormal feces composition', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366652, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030988', 'dysosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366653, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004825', 'increased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366654, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003091', 'abnormal cell migration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366655, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004009', 'abnormal diastolic filling velocity', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366656, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011048', 'decreased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366657, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008558', 'abnormal interferon-beta secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366658, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031128', 'cardiovascular shunt', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366659, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008671', 'abnormal interleukin-13 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366660, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011994', 'increased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366661, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0014026', 'abnormal respiratory epithelial transmembrane transport', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366662, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003479', 'abnormal nerve fiber response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366663, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366664, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010073', 'decreased pruritus', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366665, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005672', 'increased susceptibility to graft versus host disease', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366666, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003079', 'decreased susceptibility to induced joint inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366667, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002421', 'abnormal cell-mediated immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366668, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008663', 'increased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366669, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003394', 'increased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366670, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366671, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003897', 'abnormal ST segment', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366672, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004155', 'decreased susceptibility to induced pancreatitis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366673, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008659', 'abnormal interleukin-10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366674, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008817', 'hematoma', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366675, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0014274', 'decreased respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366676, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030132', 'periodontium inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366677, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003075', 'abnormal response to CNS ischemic injury', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366678, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020517', 'abnormal visceral yolk sac physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366679, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020937', 'increased susceptibility to Picornaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366680, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031066', 'cytokine storm', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366681, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005333', 'decreased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366682, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020921', 'abnormal susceptibility to Parvoviridae infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366683, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366684, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004149', 'increased bone strength', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366685, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366686, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012205', 'abnormal neuronal stem cell self-renewal', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366687, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020381', 'muscle gating pore current', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366688, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011046', 'abnormal lung tissue damping', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366689, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003478', 'abnormal nerve fiber response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366690, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013555', 'abnormal apocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366691, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008271', 'abnormal bone ossification', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366692, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013136', 'genital discharge', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366693, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030990', 'nerve inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366694, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366695, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004558', 'delayed allantois development', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366696, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010758', 'increased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366697, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008676', 'decreased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366698, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020932', 'decreased susceptibility to Adenoviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366699, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002327', 'abnormal respiratory function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366700, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008662', 'abnormal interleukin-12 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366701, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008703', 'decreased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366702, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004143', 'muscle hypertonia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366703, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013627', 'increased vertebra yield load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366704, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008561', 'decreased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366705, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020946', 'increased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366706, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004800', 'decreased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366707, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003701', 'elevated level of mitotic sister chromatid exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366708, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005076', 'abnormal cell differentiation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366709, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011399', 'increased endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366710, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011918', 'abnormal PQ interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366711, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002471', 'abnormal complement pathway', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366712, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003464', 'abnormal single cell response threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366713, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001836', 'abnormal antigen presentation via MHC class I', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366714, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004760', 'increased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366715, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002896', 'abnormal bone mineralization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366716, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000501', 'abnormal digestive secretion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366717, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012167', 'abnormal epigenetic regulation of gene expression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366718, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012706', 'decreased embryonic neuroepithelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366719, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004947', 'skin inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366720, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011718', 'decreased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366721, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005617', 'increased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366722, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366723, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003471', 'abnormal summary potential threshold', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366724, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002870', 'decreased anti-insulin autoantibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366725, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005501', 'abnormal skin physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366726, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010155', 'abnormal intestine physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366727, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366728, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002314', 'abnormal respiratory mechanics', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366729, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004799', 'increased susceptibility to experimental autoimmune encephalomyelitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366730, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008680', 'abnormal interleukin-17 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366731, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003927', 'increased cellular glucose import', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366732, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366733, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002106', 'abnormal muscle physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366734, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009062', 'impaired lectin complement pathway', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366735, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004877', 'abnormal systemic vascular resistance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366736, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001853', 'heart inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366737, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013135', 'poor circulation in tail', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366738, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002425', 'abnormal susceptibility to autoimmune disorder', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366739, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001921', 'reduced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366740, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020943', 'increased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366741, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002297', 'abnormal forced expiratory flow rates', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366742, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020949', 'increased susceptibility to Coronaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366743, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010752', 'impaired mucociliary clearance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366744, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366745, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0014200', 'abnormal respiratory epithelium physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366746, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003298', 'choking', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366747, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002336', 'abnormal pulmonary gas exchange', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366748, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020928', 'increased susceptibility to Poxviridae infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366749, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001947', 'abnormal mucociliary clearance', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366750, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020412', 'abnormal amnion physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366751, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002531', 'abnormal type I hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366752, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001666', 'abnormal intestinal absorption', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366753, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009057', 'increased interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366754, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011431', 'increased urine flow rate', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366755, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001986', 'abnormal taste sensitivity', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366756, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000751', 'myopathy', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366757, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003566', 'abnormal cell adhesion', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366758, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003787', 'abnormal imprinting', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366759, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001862', 'interstitial pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366760, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008695', 'abnormal interleukin-3 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366761, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008564', 'increased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366762, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005613', 'increased susceptibility to type II hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366763, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020184', 'abnormal susceptibility to parasitic infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366764, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004085', 'abnormal heartbeat', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366765, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012567', 'increased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366766, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366767, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031092', 'dysgeusia', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366768, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001851', 'eye inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366769, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001943', 'abnormal respiration', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366770, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009785', 'abnormal susceptibility to infection induced morbidity/mortality', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366771, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003116', 'rickets', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366772, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005025', 'abnormal response to infection', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366773, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020935', 'decreased susceptibility to Retroviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366774, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008751', 'abnormal interleukin level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366775, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366776, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008683', 'abnormal interleukin-18 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366777, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031435', 'abnormal copulatory plug biosynthesis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366778, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009046', 'muscle twitch', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366779, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002412', 'increased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366780, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004824', 'decreased susceptibility to experimental autoimmune myasthenia gravis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366781, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008708', 'increased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366782, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008673', 'decreased interleukin-13 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366783, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012556', 'increased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366784, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002322', 'abnormal respiratory transport', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366785, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010954', 'abnormal cellular respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366786, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009045', 'muscle tetany', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366787, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001844', 'autoimmune response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366788, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008652', 'decreased interleukin-1 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366789, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031111', 'meningoencephalitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366790, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006002', 'abnormal small intestinal transit time', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366791, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008707', 'abnormal interleukin-7 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366792, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008666', 'increased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366793, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004213', 'abnormal umami taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366794, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002534', 'abnormal type IV hypersensitivity reaction', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366795, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020154', 'impaired humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366796, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366797, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366798, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003259', 'nausea', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366799, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031170', 'abnormal vasculature physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366800, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008664', 'decreased interleukin-12 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366801, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011763', 'urethritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366802, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012554', 'increased serum complement activity', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366803, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020147', 'abnormal defecation amount', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366804, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030129', 'tongue inflammation', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366805, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020924', 'abnormal susceptibility to Hepadnaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366806, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366807, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010680', 'abnormal skin adnexa physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366808, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020142', 'increased anti-sperm antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366809, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031055', 'bronchitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366810, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008944', 'decreased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366811, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003412', 'abnormal afterhyperpolarization', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366812, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013907', 'abnormal cerebrospinal fluid flow', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366813, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002723', 'abnormal immune serum protein physiology', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366814, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020940', 'increased susceptibility to Togaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366815, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031469', 'abnormal pinocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366816, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031086', 'wheezing', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366817, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005044', 'sepsis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366818, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004510', 'myositis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366819, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005363', 'decreased susceptibility to prion infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366820, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008674', 'abnormal interleukin-15 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366821, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013556', 'abnormal holocrine gland physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366822, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010539', 'decreased level of surface class II molecules', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366823, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001872', 'sinus inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366824, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002419', 'abnormal innate immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366825, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366826, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000351', 'increased cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366827, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003393', 'decreased cardiac output', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366828, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031306', 'abnormal cartilage physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366829, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008860', 'abnormal hair cycle telogen phase', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366830, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001933', 'abnormal litter size', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366831, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004512', 'anosmia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366832, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031224', 'abnormal CXCL10 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366833, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004826', 'decreased susceptibility to experimental autoimmune thyroiditis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366834, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008688', 'decreased interleukin-2 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366835, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001598', 'abnormal blood viscosity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366836, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013645', 'increased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366837, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003726', 'decreased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366838, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008555', 'abnormal interferon secretion', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366839, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003278', 'esophageal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366840, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366841, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020414', 'abnormal fibroblast physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366842, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013639', 'decreased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366843, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008001', 'hypochlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366844, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000313', 'abnormal cell death', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366845, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008562', 'increased interferon-alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366846, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009473', 'abnormal skin exfoliation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366847, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002254', 'reproductive system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366848, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020000', 'abnormal response to antigen', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366849, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008734', 'decreased susceptibility to endotoxin shock', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366850, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031126', 'gangrene', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366851, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366852, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001800', 'abnormal humoral immune response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366853, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010381', 'abnormal dosage compensation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366854, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011047', 'increased lung tissue damping', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366855, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013752', 'stridor', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366856, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001867', 'rhinitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366857, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001951', 'abnormal breathing pattern', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366858, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001663', 'abnormal digestive system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366859, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011809', 'abnormal anoikis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366860, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366861, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366862, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003467', 'abnormal single cell response intensity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366863, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005350', 'increased susceptibility to autoimmune disorder', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366864, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030991', 'optic nerve inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366865, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002272', 'abnormal nervous system electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366866, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008737', 'abnormal spleen physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366867, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008007', 'abnormal cellular replicative senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366868, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012685', 'abnormal primitive streak elongation', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366869, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366870, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001846', 'increased inflammatory response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366871, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008861', 'abnormal hair shedding', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366872, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000743', 'muscle spasm', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366873, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008693', 'increased interleukin-23a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366874, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366875, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008679', 'decreased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366876, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000740', 'impaired smooth muscle contractility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366877, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366878, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011720', 'abnormal ossification involved in bone remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366879, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010559', 'heart block', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366880, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020948', 'abnormal susceptibility to Coronaviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366881, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004751', 'increased length of allograft survival', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366882, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366883, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010504', 'abnormal RR interval', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366884, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005410', 'abnormal fertilization', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366885, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002411', 'decreased susceptibility to bacterial infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366886, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020933', 'abnormal susceptibility to Retroviridae infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366887, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001837', 'defective assembly of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366888, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012555', 'decreased cell death', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366889, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010695', 'abnormal blood pressure regulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366890, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010071', 'abnormal pruritus', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366891, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002128', 'abnormal blood circulation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366892, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001542', 'abnormal bone strength', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366893, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008677', 'abnormal interleukin-16 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366894, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031088', 'coughing', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366895, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003898', 'abnormal QRS complex', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366896, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003824', 'decreased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366897, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366898, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002626', 'increased heart rate', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366899, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366900, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008702', 'increased interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366901, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012202', 'abnormal endothelial cell proliferation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366902, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0014037', 'stranguria', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366903, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006001', 'abnormal intestinal transit time', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366904, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004037', 'increased muscle relaxation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366905, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008546', 'abnormal vesicle-mediated transport', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366906, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011717', 'increased interleukin-8 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366907, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020947', 'decreased susceptibility to Orthomyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366908, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020386', 'adipose tissue inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366909, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002420', 'abnormal adaptive immunity', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366910, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008667', 'decreased interleukin-12a secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366911, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008692', 'abnormal interleukin-23a secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366912, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012111', 'failure of morula compaction', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366913, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008002', 'hyperchlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366914, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001634', 'internal hemorrhage', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366915, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031302', 'syncope', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366916, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002842', 'increased systemic arterial blood pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366917, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008684', 'increased interleukin-18 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366918, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008565', 'decreased interferon-beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366919, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010756', 'decreased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366920, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031091', 'hypogeusia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366921, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030909', 'abnormal melanocyte adhesion', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366922, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012565', 'perivasculitis', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366923, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008721', 'abnormal chemokine level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366924, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020953', 'decreased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366925, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031246', 'abnormal CCL3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366926, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0021016', 'decreased tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366927, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366928, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008943', 'increased sensitivity to induced cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366929, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013638', 'decreased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366930, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010950', 'abnormal lung hysteresivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366931, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013971', 'blood in lymph vessels', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366932, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004031', 'insulitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366933, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008711', 'increased interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366934, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001924', 'infertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366935, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030987', 'spinal cord inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366936, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011762', 'renal/urinary system inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366937, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011952', 'decreased cardiac stroke volume', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366938, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005398', 'decreased susceptibility to fungal infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366939, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020848', 'abnormal exocytosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366940, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010822', 'pneumothorax', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366941, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008273', 'abnormal intramembranous bone ossification', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366942, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004145', 'abnormal muscle electrophysiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366943, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001908', 'abnormal somatosensory cortex physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366944, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008675', 'increased interleukin-15 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366945, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008750', 'abnormal interferon level', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366946, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001858', 'intestinal inflammation', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366947, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003823', 'increased left ventricle developed pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366948, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002634', 'abnormal sensorimotor gating', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366949, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001963', 'abnormal hearing physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366950, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009792', 'seborrheic dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366951, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366952, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366953, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0030924', 'early exit from telogen phase', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366954, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010143', 'enhanced fertility', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366955, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001869', 'pancreas inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366956, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008686', 'abnormal interleukin-2 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366957, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006080', 'brain ischemia', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366958, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010211', 'abnormal acute phase protein level', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366959, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001668', 'abnormal intestinal fructose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366960, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008198', 'abnormal follicular dendritic cell antigen presentation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366961, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011194', 'abnormal hair follicle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366962, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004122', 'abnormal sinus arrhythmia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366963, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009786', 'decreased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366964, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004796', 'increased anti-histone antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366965, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013559', 'abnormal exocrine gland physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366966, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366967, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020186', 'abnormal susceptibility to bacterial infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366968, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008699', 'increased interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366969, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009787', 'increased susceptibility to infection induced morbidity/mortality', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366970, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003698', 'abnormal male reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366971, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008776', 'increased right ventricle peak pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366972, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001838', 'defective intracellular transport of class I molecules', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366973, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001670', 'abnormal intestinal mineral absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366974, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004211', 'abnormal sour taste sensitivity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366975, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366976, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000427', 'abnormal hair cycle', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366977, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002473', 'impaired complement classical pathway', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366978, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001790', 'abnormal immune system physiology', 0.5833333333333334, 7.400946880077414, 2.0777918599750294, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366979, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020952', 'increased susceptibility to Paramyxoviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366980, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008653', 'abnormal interleukin-1 alpha secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366981, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031425', 'enhanced male fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366982, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366983, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003875', 'abnormal hair follicle regression', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366984, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020097', 'low mean heart rate adaptation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366985, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013637', 'increased femur stiffness', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366986, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005532', 'abnormal vascular resistance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366987, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008747', 'abnormal T cell anergy', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366988, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366989, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031051', 'lymph node hemorrhage', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366990, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005616', 'decreased susceptibility to type IV hypersensitivity reaction', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366991, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004759', 'decreased mitotic index', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366992, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012608', 'abnormal complement C5 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366993, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031221', 'abnormal CXCL10 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366994, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020138', 'delayed bone mineralization', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366995, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000503', 'excessive digestive secretion', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366996, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009247', 'meteorism', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366997, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009562', 'abnormal odor adaptation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(366998, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031110', 'meningitis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(366999, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001914', 'hemorrhage', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367000, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005088', 'increased acute inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367001, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001866', 'nasal inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367002, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004011', 'decreased diastolic filling velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367003, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002933', 'joint inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367004, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001845', 'abnormal inflammatory response', 0.56, 7.400946880077414, 2.0358119394588865, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367005, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002164', 'abnormal gland physiology', 0.48, 5.059610039003922, 1.5584007246924272, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367006, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367007, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000343', 'abnormal response to cardiac infarction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367008, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008650', 'abnormal interleukin-1 secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367009, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008669', 'increased interleukin-12b secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367010, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003699', 'abnormal female reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367011, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010505', 'abnormal T wave', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367012, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031104', 'crackles', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367013, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001648', 'abnormal apoptosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367014, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003674', 'oxidative stress', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367015, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008654', 'increased interleukin-1 alpha secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367016, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367017, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013640', 'increased bone stiffness', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367018, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0005042', 'abnormal level of surface class II molecules', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367019, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031241', 'decreased CSF3 level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367020, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0002993', 'arthritis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367021, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0009384', 'cardiac valve regurgitation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367022, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013634', 'increased femur fracture load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367023, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020926', 'decreased susceptibility to Hepadnaviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367024, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0011805', 'decreased cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367025, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008260', 'abnormal autophagy', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367026, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001761', 'abnormal urination pattern', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367027, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008678', 'increased interleukin-16 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367028, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020155', 'enhanced humoral immune response', 0.5384615384615384, 7.400946880077414, 1.9962778471742373, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367029, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020944', 'decreased susceptibility to Flaviviridae infection', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367030, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004803', 'increased susceptibility to autoimmune diabetes', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367031, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031125', 'aspiration pneumonia', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367032, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010741', 'abnormal melanocyte proliferation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367033, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008709', 'decreased interleukin-7 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367034, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003889', 'enhanced sensorimotor gating', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367035, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367036, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031424', 'enhanced female fertility', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367037, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020916', 'increased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367038, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001984', 'abnormal olfaction', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367039, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0006082', 'CNS inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367040, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008544', 'impaired olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367041, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008003', 'achlorhydria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367042, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008690', 'increased interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367043, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0000350', 'abnormal cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367044, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008749', 'abnormal peripheral T cell anergy', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367045, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008656', 'abnormal interleukin-1 beta secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367046, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013632', 'increased femur maximal load', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367047, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0031053', 'pleuritis', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367048, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001819', 'abnormal immune cell physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367049, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004046', 'abnormal mitosis', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367050, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0014047', 'abnormal gut-associated lymphoid tissue physiology', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367051, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013296', 'abnormal susceptibility to induced colitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367052, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367053, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367054, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012123', 'abnormal bronchoconstrictive response', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367055, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003725', 'increased autoantibody level', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367056, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013646', 'decreased energy dissipated prior to femur fracture', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367057, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008814', 'decreased nerve conduction velocity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367058, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020917', 'decreased susceptibility to Herpesvirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367059, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367060, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003303', 'peritoneal inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367061, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020919', 'increased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367062, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0012704', 'abnormal embryonic neuroepithelial cell proliferation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367063, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001945', 'bronchoconstriction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367064, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0008775', 'abnormal heart ventricle pressure', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367065, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003186', 'abnormal redox activity', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367066, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0013475', 'delayed reproductive senescence', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367067, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0020920', 'decreased susceptibility to Ortervirales infection', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367068, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0003767', 'palate inflammation', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367069, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0001669', 'abnormal intestinal glucose absorption', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367070, 'HP:0003613', 'Antiphospholipid antibody positivity', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367071, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0011483', 'renal glomerular synechia', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367072, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0011349', 'abnormal renal glomerulus basement membrane thickness', 0.42592592592592593, 9.804092483287297, 2.0434816291827906, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367073, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0011855', 'abnormal glomerular filtration barrier morphology', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367074, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0011506', 'glomerular crescent', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367075, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0011561', 'renal glomerulus lipidosis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367076, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0002827', 'abnormal renal corpuscle morphology', 0.40425531914893614, 9.692263881549227, 1.9794315418097665, 'UPHENO:0086675', 'abnormal renal corpuscle morphology'),
(367077, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0005325', 'abnormal renal glomerulus morphology', 0.4166666666666667, 9.804092483287297, 2.021147826039214, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367078, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0000523', 'cortical renal glomerulopathies', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367079, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0020518', 'renal glomerular protein deposits', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367080, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0011377', 'renal glomerulus fibrosis', 0.4339622641509434, 9.804092483287297, 2.0626696710798362, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367081, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0021199', 'abnormal susceptibility to glomerulonephritis', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367082, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0011294', 'renal glomerulus hypertrophy', 0.4107142857142857, 9.804092483287297, 2.006659124353247, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367083, 'HP:0033602', 'Glomerular hyaline subepithelial deposits', 'MP:0011567', 'increased renal glomerulus lobularity', 0.40816326530612246, 9.804092483287297, 2.0004175567470295, 'UPHENO:0076738', 'abnormal renal glomerulus morphology'),
(367084, 'HP:0410346', 'Increased urinary galactosylated oligosaccharide', 'MP:0011473', 'increased urine glycosaminoglycan level', 0.41509433962264153, 9.50911518495075, 1.9867510886099355, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(367085, 'HP:0410346', 'Increased urinary galactosylated oligosaccharide', 'MP:0030612', 'organic aciduria', 0.46808510638297873, 9.50911518495075, 2.109757140752383, 'UPHENO:0068110', 'increased level of chemical entity in urine'),
(367086, 'HP:0410346', 'Increased urinary galactosylated oligosaccharide', 'MP:0001759', 'increased urine glucose level', 0.4107142857142857, 10.668547812575419, 2.09325703019257, 'UPHENO:0052116', 'abnormal independent continuant carbohydrate level'),
(367087, 'HP:0005187', 'Progressive joint destruction', 'MP:0000065', 'abnormal bone marrow cavity morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367088, 'HP:0005187', 'Progressive joint destruction', 'MP:0012071', 'increased susceptibility to osteoporosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367089, 'HP:0005187', 'Progressive joint destruction', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367090, 'HP:0005187', 'Progressive joint destruction', 'MP:0002113', 'abnormal skeleton development', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367091, 'HP:0005187', 'Progressive joint destruction', 'MP:0002932', 'abnormal joint morphology', 0.5416666666666666, 8.414032639097075, 2.134853862175172, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367092, 'HP:0005187', 'Progressive joint destruction', 'MP:0004214', 'abnormal long bone diaphysis morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367093, 'HP:0005187', 'Progressive joint destruction', 'MP:0002163', 'abnormal gland morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367094, 'HP:0005187', 'Progressive joint destruction', 'MP:0014024', 'increased subchondral bone mineral content', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367095, 'HP:0005187', 'Progressive joint destruction', 'MP:0012072', 'decreased susceptibility to osteoporosis', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367096, 'HP:0005187', 'Progressive joint destruction', 'MP:0030878', 'abnormal fibrous joint morphology', 0.5, 8.414032639097075, 2.0511012455626214, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367097, 'HP:0005187', 'Progressive joint destruction', 'MP:0013630', 'increased bone trabecular spacing', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367098, 'HP:0005187', 'Progressive joint destruction', 'MP:0004703', 'abnormal vertebral column morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367099, 'HP:0005187', 'Progressive joint destruction', 'MP:0000163', 'abnormal cartilage morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367100, 'HP:0005187', 'Progressive joint destruction', 'MP:0003200', 'calcified joint', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367101, 'HP:0005187', 'Progressive joint destruction', 'MP:0031348', 'bone fibrous dysplasia', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367102, 'HP:0005187', 'Progressive joint destruction', 'MP:0030222', 'hyperostosis', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367103, 'HP:0005187', 'Progressive joint destruction', 'MP:0030805', 'abnormal limb joint morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367104, 'HP:0005187', 'Progressive joint destruction', 'MP:0004625', 'abnormal rib joint morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367105, 'HP:0005187', 'Progressive joint destruction', 'MP:0005605', 'increased bone mass', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367106, 'HP:0005187', 'Progressive joint destruction', 'MP:0013614', 'abnormal areal bone mineral density', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367107, 'HP:0005187', 'Progressive joint destruction', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367108, 'HP:0005187', 'Progressive joint destruction', 'MP:0030484', 'abnormal osteocyte lacuna morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367109, 'HP:0005187', 'Progressive joint destruction', 'MP:0030820', 'abnormal pectoral girdle joint morphology', 0.41935483870967744, 8.414032639097075, 1.8784209592810968, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367110, 'HP:0005187', 'Progressive joint destruction', 'MP:0000164', 'abnormal cartilage development', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367111, 'HP:0005187', 'Progressive joint destruction', 'MP:0031312', 'spondylolysis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367112, 'HP:0005187', 'Progressive joint destruction', 'MP:0030795', 'joint dislocation', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367113, 'HP:0005187', 'Progressive joint destruction', 'MP:0000133', 'abnormal long bone metaphysis morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367114, 'HP:0005187', 'Progressive joint destruction', 'MP:0006430', 'abnormal elastic cartilage morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367115, 'HP:0005187', 'Progressive joint destruction', 'MP:0000997', 'abnormal synovial joint capsule morphology', 0.4642857142857143, 8.414032639097075, 1.9764906156788347, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367116, 'HP:0005187', 'Progressive joint destruction', 'MP:0030866', 'abnormal synovial joint membrane morphology', 0.4642857142857143, 8.414032639097075, 1.9764906156788347, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367117, 'HP:0005187', 'Progressive joint destruction', 'MP:0005508', 'abnormal skeleton morphology', 0.5217391304347826, 4.825104621810128, 1.5866461135489751, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367118, 'HP:0005187', 'Progressive joint destruction', 'MP:0005504', 'abnormal ligament morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367119, 'HP:0005187', 'Progressive joint destruction', 'MP:0009877', 'exostosis', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367120, 'HP:0005187', 'Progressive joint destruction', 'MP:0000150', 'abnormal rib morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367121, 'HP:0005187', 'Progressive joint destruction', 'MP:0010932', 'increased trabecular bone connectivity density', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367122, 'HP:0005187', 'Progressive joint destruction', 'MP:0010971', 'abnormal periosteum morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367123, 'HP:0005187', 'Progressive joint destruction', 'MP:0030804', 'abnormal synovial joint morphology', 0.5, 8.414032639097075, 2.0511012455626214, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367124, 'HP:0005187', 'Progressive joint destruction', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367125, 'HP:0005187', 'Progressive joint destruction', 'MP:0004624', 'abnormal thoracic cage morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367126, 'HP:0005187', 'Progressive joint destruction', 'MP:0030865', 'abnormal synovial joint cavity morphology', 0.4642857142857143, 8.414032639097075, 1.9764906156788347, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367127, 'HP:0005187', 'Progressive joint destruction', 'MP:0010122', 'abnormal bone mineral content', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367128, 'HP:0005187', 'Progressive joint destruction', 'MP:0008150', 'decreased diameter of long bones', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367129, 'HP:0005187', 'Progressive joint destruction', 'MP:0003385', 'abnormal body wall morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367130, 'HP:0005187', 'Progressive joint destruction', 'MP:0031349', 'monostotic fibrous dysplasia', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367131, 'HP:0005187', 'Progressive joint destruction', 'MP:0020009', 'abnormal bone mineral density of femur', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367132, 'HP:0005187', 'Progressive joint destruction', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367133, 'HP:0005187', 'Progressive joint destruction', 'MP:0003797', 'abnormal compact bone morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367134, 'HP:0005187', 'Progressive joint destruction', 'MP:0010970', 'abnormal compact bone lamellar structure', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367135, 'HP:0005187', 'Progressive joint destruction', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367136, 'HP:0005187', 'Progressive joint destruction', 'MP:0010678', 'abnormal skin adnexa morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367137, 'HP:0005187', 'Progressive joint destruction', 'MP:0005500', 'abnormal gustatory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367138, 'HP:0005187', 'Progressive joint destruction', 'MP:0009807', 'abnormal pelvic ligament morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367139, 'HP:0005187', 'Progressive joint destruction', 'MP:0013304', 'osteophytes', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367140, 'HP:0005187', 'Progressive joint destruction', 'MP:0009918', 'abnormal stylohyoid ligament morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367141, 'HP:0005187', 'Progressive joint destruction', 'MP:0003795', 'abnormal bone structure', 0.5, 4.825104621810128, 1.5532392960857848, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367142, 'HP:0005187', 'Progressive joint destruction', 'MP:0010968', 'decreased compact bone area', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367143, 'HP:0005187', 'Progressive joint destruction', 'MP:0010963', 'abnormal compact bone volume', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367144, 'HP:0005187', 'Progressive joint destruction', 'MP:0010967', 'increased compact bone area', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367145, 'HP:0005187', 'Progressive joint destruction', 'MP:0000130', 'abnormal trabecular bone morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367146, 'HP:0005187', 'Progressive joint destruction', 'MP:0010925', 'abnormal osteoid volume', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367147, 'HP:0005187', 'Progressive joint destruction', 'MP:0005499', 'abnormal olfactory system morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367148, 'HP:0005187', 'Progressive joint destruction', 'MP:0010874', 'abnormal bone volume', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367149, 'HP:0005187', 'Progressive joint destruction', 'MP:0002937', 'synovial hyperemia', 0.48148148148148145, 8.414032639097075, 2.01275952371514, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367150, 'HP:0005187', 'Progressive joint destruction', 'MP:0004174', 'abnormal spine curvature', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367151, 'HP:0005187', 'Progressive joint destruction', 'MP:0002111', 'abnormal tail morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367152, 'HP:0005187', 'Progressive joint destruction', 'MP:0014025', 'decreased subchondral bone mineral content', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367153, 'HP:0005187', 'Progressive joint destruction', 'MP:0011642', 'abnormal bone collagen fibril morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367154, 'HP:0005187', 'Progressive joint destruction', 'MP:0031350', 'polyostotic fibrous dysplasia', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367155, 'HP:0005187', 'Progressive joint destruction', 'MP:0013629', 'abnormal bone trabecular spacing', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367156, 'HP:0005187', 'Progressive joint destruction', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367157, 'HP:0005187', 'Progressive joint destruction', 'MP:0010933', 'decreased trabecular bone connectivity density', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367158, 'HP:0005187', 'Progressive joint destruction', 'MP:0010123', 'increased bone mineral content', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367159, 'HP:0005187', 'Progressive joint destruction', 'MP:0013941', 'abnormal enthesis morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367160, 'HP:0005187', 'Progressive joint destruction', 'MP:0003723', 'abnormal long bone morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367161, 'HP:0005187', 'Progressive joint destruction', 'MP:0010867', 'abnormal bone trabecula morphology', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367162, 'HP:0005187', 'Progressive joint destruction', 'MP:0010931', 'abnormal trabecular bone connectivity density', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367163, 'HP:0005187', 'Progressive joint destruction', 'MP:0030819', 'abnormal pelvic girdle joint morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367164, 'HP:0005187', 'Progressive joint destruction', 'MP:0010877', 'abnormal trabecular bone volume', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367165, 'HP:0005187', 'Progressive joint destruction', 'MP:0013631', 'decreased bone trabecular spacing', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367166, 'HP:0005187', 'Progressive joint destruction', 'MP:0010966', 'abnormal compact bone area', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367167, 'HP:0005187', 'Progressive joint destruction', 'MP:0030486', 'abnormal osteocyte canaliculus morphology', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367168, 'HP:0005187', 'Progressive joint destruction', 'MP:0006431', 'abnormal fibrocartilage morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367169, 'HP:0005187', 'Progressive joint destruction', 'MP:0031313', 'spondylolisthesis', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367170, 'HP:0005187', 'Progressive joint destruction', 'MP:0006429', 'abnormal hyaline cartilage morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367171, 'HP:0005187', 'Progressive joint destruction', 'MP:0013613', 'abnormal volumetric bone mineral density', 0.41379310344827586, 4.825104621810128, 1.4130092058870078, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367172, 'HP:0005187', 'Progressive joint destruction', 'MP:0002657', 'chondrodystrophy', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367173, 'HP:0005187', 'Progressive joint destruction', 'MP:0004509', 'abnormal pelvic girdle bone morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367174, 'HP:0005187', 'Progressive joint destruction', 'MP:0010124', 'decreased bone mineral content', 0.46153846153846156, 4.825104621810128, 1.492304045398379, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367175, 'HP:0005187', 'Progressive joint destruction', 'MP:0002114', 'abnormal axial skeleton morphology', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367176, 'HP:0005187', 'Progressive joint destruction', 'MP:0010119', 'abnormal bone mineral density', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367177, 'HP:0005187', 'Progressive joint destruction', 'MP:0014134', 'abnormal embryo morphology', 0.4166666666666667, 2.6504988612427964, 1.0508922520971558, 'UPHENO:0076692', 'abnormal anatomical entity morphology'),
(367178, 'HP:0005187', 'Progressive joint destruction', 'MP:0010924', 'abnormal osteoid morphology', 0.4444444444444444, 4.825104621810128, 1.4644080520902374, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367179, 'HP:0005187', 'Progressive joint destruction', 'MP:0030879', 'abnormal syndesmosis morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367180, 'HP:0005187', 'Progressive joint destruction', 'MP:0030818', 'abnormal girdle joint morphology', 0.5, 8.414032639097075, 2.0511012455626214, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367181, 'HP:0005187', 'Progressive joint destruction', 'MP:0030877', 'abnormal symphysis morphology', 0.43333333333333335, 8.414032639097075, 1.909471343140661, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367182, 'HP:0005187', 'Progressive joint destruction', 'MP:0004508', 'abnormal pectoral girdle bone morphology', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367183, 'HP:0005187', 'Progressive joint destruction', 'MP:0000566', 'synostosis', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367184, 'HP:0005187', 'Progressive joint destruction', 'MP:0030875', 'abnormal cartilaginous joint morphology', 0.5, 8.414032639097075, 2.0511012455626214, 'UPHENO:0076767', 'abnormal skeletal joint morphology'),
(367185, 'HP:0005187', 'Progressive joint destruction', 'MP:0005422', 'osteosclerosis', 0.48, 4.825104621810128, 1.5218574895399573, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367186, 'HP:0005187', 'Progressive joint destruction', 'MP:0008151', 'increased diameter of long bones', 0.42857142857142855, 4.825104621810128, 1.4380201600727889, 'UPHENO:0076703', 'abnormal skeletal system morphology'),
(367187, 'HP:0012190', 'T-cell lymphoma', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4166666666666667, 5.816527256141925, 1.5567764847249168, 'UPHENO:0004459', 'abnormal hematopoietic system'),
(367188, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006264', 'decreased systemic arterial systolic blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367189, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0008817', 'hematoma', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367190, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011952', 'decreased cardiac stroke volume', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367191, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0005666', 'abnormal adipose tissue physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367192, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010508', 'abnormal heart electrocardiography waveform feature', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367193, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003233', 'prolonged QT interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367194, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001598', 'abnormal blood viscosity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367195, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010756', 'decreased right ventricle peak pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367196, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0009275', 'bruising', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367197, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006046', 'atrioventricular valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367198, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367199, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006143', 'increased systemic arterial diastolic blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367200, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031128', 'cardiovascular shunt', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367201, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001636', 'irregular heartbeat', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367202, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001914', 'hemorrhage', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367203, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0000233', 'abnormal blood flow velocity', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367204, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004071', 'prolonged P wave', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367205, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011951', 'increased cardiac stroke volume', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367206, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010505', 'abnormal T wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367207, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004876', 'decreased mean systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367208, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003898', 'abnormal QRS complex', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367209, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004485', 'increased response of heart to induced stress', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367210, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010504', 'abnormal RR interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367211, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001634', 'internal hemorrhage', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367212, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0009384', 'cardiac valve regurgitation', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367213, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0008775', 'abnormal heart ventricle pressure', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367214, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002952', 'ventricular cardiomyopathy', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367215, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031215', 'abnormal response to myocardial ischemic injury', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367216, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006045', 'mitral valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367217, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011929', 'abnormal aortic valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367218, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011927', 'abnormal cardiac valve flow', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367219, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0008776', 'increased right ventricle peak pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367220, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367221, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0013135', 'poor circulation in tail', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367222, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010759', 'decreased right ventricle systolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367223, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001919', 'abnormal reproductive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367224, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004084', 'abnormal cardiac muscle relaxation', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367225, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004011', 'decreased diastolic filling velocity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367226, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010697', 'abnormal systemic arterial blood pressure regulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367227, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0009732', 'ventricular premature beat', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367228, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006044', 'tricuspid valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367229, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004010', 'increased diastolic filling velocity', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367230, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002106', 'abnormal muscle physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367231, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020097', 'low mean heart rate adaptation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367232, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0012046', 'decreased susceptibility to hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367233, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004879', 'decreased systemic vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367234, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004156', 'abnormal QT variability', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367235, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010554', 'shortened HV interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367236, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003824', 'decreased left ventricle developed pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367237, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003882', 'abnormal pulse pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367238, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003037', 'increased myocardial infarct size', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367239, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003035', 'decreased pulmonary vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367240, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003394', 'increased cardiac output', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367241, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367242, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010394', 'decreased QRS amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367243, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004558', 'delayed allantois development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367244, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003034', 'increased pulmonary vascular resistance', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367245, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004875', 'increased mean systemic arterial blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367246, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004215', 'abnormal myocardial fiber physiology', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367247, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003393', 'decreased cardiac output', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367248, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011919', 'abnormal R wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367249, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031130', 'right-to-left shunt', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367250, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010506', 'prolonged RR interval', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367251, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003899', 'abnormal QT interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367252, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003039', 'increased time of peak ischemic contracture', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367253, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004122', 'abnormal sinus arrhythmia', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367254, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0012557', 'decreased calcium uptake by cardiac muscle', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367255, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003042', 'decreased time of onset of induced ischemic contracture', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367256, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010519', 'atrioventricular block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367257, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367258, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031216', 'decreased susceptibility to myocardial ischemic injury', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367259, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010520', 'sinoatrial block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367260, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004070', 'abnormal P wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367261, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006048', 'pulmonary valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367262, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0008950', 'ventricular tachycardia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367263, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010553', 'prolonged HV interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367264, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0012045', 'increased susceptibility to hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367265, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020095', 'abnormal mean heart rate adaptation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367266, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006265', 'increased pulse pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367267, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010515', 'abnormal Q wave', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367268, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0000231', 'hypertension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367269, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003822', 'decreased left ventricle systolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367270, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002842', 'increased systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367271, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0000304', 'abnormal cardiac stroke volume', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367272, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006141', 'abnormal atrioventricular node conduction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367273, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001627', 'abnormal cardiac output', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367274, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002626', 'increased heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367275, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0000230', 'abnormal systemic arterial blood pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367276, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004116', 'abnormal atrioventricular bundle conduction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367277, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003823', 'increased left ventricle developed pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367278, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020100', 'decreased susceptibility to diet-induced aortic fatty streak lesions', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367279, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367280, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011022', 'abnormal circadian regulation of systemic arterial blood pressure', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367281, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020092', 'abnormal susceptibility to aortic cartilaginous metaplasia', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367282, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003821', 'decreased left ventricle diastolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367283, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010510', 'absent P wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367284, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003901', 'abnormal PR interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367285, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011926', 'abnormal heart valve physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367286, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002843', 'decreased systemic arterial blood pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367287, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011925', 'abnormal heart echocardiography feature', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367288, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001629', 'abnormal heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367289, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0012558', 'increased calcium uptake by cardiac muscle', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367290, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367291, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003929', 'decreased heart rate variability', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367292, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006138', 'congestive heart failure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367293, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0013134', 'poor circulation in autopods', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367294, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011021', 'abnormal circadian regulation of heart rate', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367295, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004072', 'abnormal frontal plane axis', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367296, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010757', 'decreased right ventricle diastolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367297, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0005333', 'decreased heart rate', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367298, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003928', 'increased heart rate variability', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367299, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004009', 'abnormal diastolic filling velocity', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367300, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010637', 'sinus bradycardia', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367301, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010511', 'shortened PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367302, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0005621', 'abnormal cell physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367303, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003900', 'shortened QT interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367304, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010507', 'shortened RR interval', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367305, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003633', 'abnormal nervous system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367306, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010758', 'increased right ventricle systolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367307, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031092', 'dysgeusia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367308, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011938', 'prolonged PP interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367309, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031152', 'subcutaneous hemorrhage', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367310, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0012685', 'abnormal primitive streak elongation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367311, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002128', 'abnormal blood circulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367312, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003438', 'abnormal carotid body physiology', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367313, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002133', 'abnormal respiratory system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367314, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010634', 'increased QRS amplitude', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367315, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010552', 'abnormal HV interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367316, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006142', 'abnormal sinoatrial node conduction', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367317, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004012', 'increased pulmonary artery pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367318, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006144', 'increased systemic arterial systolic blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367319, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367320, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010636', 'bundle branch block', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367321, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020099', 'increased susceptibility to diet-induced aortic fatty streak lesions', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367322, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011953', 'prolonged PQ interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367323, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.5185185185185185, 8.605269980670606, 2.1123427377746262, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367324, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031129', 'left-to-right shunt', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367325, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003033', 'abnormal pulmonary vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367326, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003547', 'abnormal pulmonary pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367327, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367328, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004216', 'salt-resistant hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367329, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0000343', 'abnormal response to cardiac infarction', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367330, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006049', 'semilunar valve regurgitation', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367331, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010695', 'abnormal blood pressure regulation', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367332, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0000427', 'abnormal hair cycle', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367333, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010393', 'shortened QRS complex duration', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367334, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011920', 'abnormal S wave', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367335, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001599', 'abnormal blood volume', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367336, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003819', 'increased left ventricle diastolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367337, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001790', 'abnormal immune system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367338, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006114', 'cardiac murmur', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367339, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003041', 'increased time of onset of induced ischemic contracture', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367340, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011937', 'shortened PP interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367341, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004878', 'increased systemic vascular resistance', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367342, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001596', 'hypotension', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367343, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010754', 'abnormal heart left ventricle pressure', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367344, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004217', 'salt-sensitive hypertension', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367345, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006266', 'decreased pulse pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367346, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001633', 'poor circulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367347, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003897', 'abnormal ST segment', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367348, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010509', 'decreased P wave amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367349, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010559', 'heart block', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367350, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004085', 'abnormal heartbeat', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367351, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367352, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001533', 'abnormal skeleton physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367353, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0005435', 'hemoperitoneum', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367354, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010516', 'absent Q wave', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367355, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003137', 'abnormal impulse conducting system conduction', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367356, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020345', 'abnormal myocardial fiber currents', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367357, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003040', 'decreased time of peak ischemic contracture', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367358, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020098', 'abnormal susceptibility to diet-induced aortic fatty streak lesions', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367359, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004877', 'abnormal systemic vascular resistance', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367360, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003038', 'decreased myocardial infarct size', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367361, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367362, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367363, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011931', 'abnormal pulmonary valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367364, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011930', 'abnormal tricuspid valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367365, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010392', 'prolonged QRS complex duration', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367366, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0009698', 'heart hemorrhage', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367367, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0000249', 'abnormal blood vessel physiology', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367368, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011936', 'abnormal PP interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367369, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004013', 'decreased pulmonary artery pressure', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367370, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010512', 'absent PR interval', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367371, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0008777', 'increased right ventricle diastolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367372, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0005330', 'cardiomyopathy', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367373, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367374, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0005532', 'abnormal vascular resistance', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367375, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031217', 'increased susceptibility to myocardial ischemic injury', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367376, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0014020', 'intramural bleeding in blood vessel wall', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367377, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001986', 'abnormal taste sensitivity', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367378, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003820', 'increased left ventricle systolic pressure', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367379, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004486', 'decreased response of heart to induced stress', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367380, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011954', 'shortened PQ interval', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367381, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367382, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001663', 'abnormal digestive system physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367383, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031302', 'syncope', 0.5, 8.605269980670606, 2.0742793906162453, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367384, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001984', 'abnormal olfaction', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367385, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010513', 'abnormal ventricular activation time', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367386, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006047', 'aortic valve regurgitation', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367387, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0003896', 'prolonged PR interval', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367388, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011918', 'abnormal PQ interval', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367389, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010571', 'shortened ST segment', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367390, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0006263', 'decreased systemic arterial diastolic blood pressure', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367391, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010570', 'prolonged ST segment', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367392, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0011928', 'abnormal mitral valve flow', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367393, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031170', 'abnormal vasculature physiology', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367394, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0002972', 'abnormal cardiac muscle contractility', 0.4117647058823529, 8.605269980670606, 1.8823778745589508, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367395, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010560', 'intraventricular block', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367396, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020096', 'high mean heart rate adaptation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367397, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367398, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367399, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010631', 'increased Q wave amplitude', 0.4375, 8.605269980670606, 1.9403107010330563, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367400, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367401, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0031192', 'coronary artery spasm', 0.42424242424242425, 8.605269980670606, 1.9106858972265057, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367402, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.4827586206896552, 8.605269980670606, 2.0382022143375855, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367403, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0010514', 'fragmented QRS complex', 0.45161290322580644, 8.605269980670606, 1.9713576436082143, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367404, 'HP:0012666', 'Severely reduced left ventricular ejection fraction', 'MP:0004484', 'abnormal response of heart to induced stress', 0.4666666666666667, 8.605269980670606, 2.0039442750850838, 'UPHENO:0002406', 'abnormality of cardiovascular system physiology'),
(367405, 'HP:0034245', 'Fetal head anomaly', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367406, 'HP:0034245', 'Fetal head anomaly', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367407, 'HP:0034245', 'Fetal head anomaly', 'MP:0000428', 'abnormal craniofacial morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367408, 'HP:0034245', 'Fetal head anomaly', 'MP:0010678', 'abnormal skin adnexa morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367409, 'HP:0034245', 'Fetal head anomaly', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367410, 'HP:0034245', 'Fetal head anomaly', 'MP:0002109', 'abnormal limb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367411, 'HP:0034245', 'Fetal head anomaly', 'MP:0010233', 'hairless tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367412, 'HP:0034245', 'Fetal head anomaly', 'MP:0014134', 'abnormal embryo morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367413, 'HP:0034245', 'Fetal head anomaly', 'MP:0002132', 'abnormal respiratory system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367414, 'HP:0034245', 'Fetal head anomaly', 'MP:0003384', 'abnormal ventral body wall morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367415, 'HP:0034245', 'Fetal head anomaly', 'MP:0005499', 'abnormal olfactory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367416, 'HP:0034245', 'Fetal head anomaly', 'MP:0002925', 'abnormal cardiovascular development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367417, 'HP:0034245', 'Fetal head anomaly', 'MP:0013113', 'greasy tail', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367418, 'HP:0034245', 'Fetal head anomaly', 'MP:0008923', 'thoracoschisis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367419, 'HP:0034245', 'Fetal head anomaly', 'MP:0005508', 'abnormal skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367420, 'HP:0034245', 'Fetal head anomaly', 'MP:0013118', 'swellings', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367421, 'HP:0034245', 'Fetal head anomaly', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367422, 'HP:0034245', 'Fetal head anomaly', 'MP:0002163', 'abnormal gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367423, 'HP:0034245', 'Fetal head anomaly', 'MP:0004134', 'abnormal chest morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367424, 'HP:0034245', 'Fetal head anomaly', 'MP:0005500', 'abnormal gustatory system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367425, 'HP:0034245', 'Fetal head anomaly', 'MP:0003632', 'abnormal nervous system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367426, 'HP:0034245', 'Fetal head anomaly', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367427, 'HP:0034245', 'Fetal head anomaly', 'MP:0003385', 'abnormal body wall morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367428, 'HP:0034245', 'Fetal head anomaly', 'MP:0000685', 'abnormal immune system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367429, 'HP:0034245', 'Fetal head anomaly', 'MP:0002108', 'abnormal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367430, 'HP:0034245', 'Fetal head anomaly', 'MP:0020982', 'abnormal skin adnexa development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367431, 'HP:0034245', 'Fetal head anomaly', 'MP:0031310', 'abnormal cyst', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367432, 'HP:0034245', 'Fetal head anomaly', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367433, 'HP:0034245', 'Fetal head anomaly', 'MP:0002111', 'abnormal tail morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367434, 'HP:0034245', 'Fetal head anomaly', 'MP:0020973', 'abnormal gland development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367435, 'HP:0034245', 'Fetal head anomaly', 'MP:0000462', 'abnormal digestive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367436, 'HP:0034245', 'Fetal head anomaly', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367437, 'HP:0034245', 'Fetal head anomaly', 'MP:0002160', 'abnormal reproductive system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367438, 'HP:0034245', 'Fetal head anomaly', 'MP:0006281', 'abnormal tail development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367439, 'HP:0034245', 'Fetal head anomaly', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367440, 'HP:0034245', 'Fetal head anomaly', 'MP:0013332', 'peliosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367441, 'HP:0034245', 'Fetal head anomaly', 'MP:0003279', 'aneurysm', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367442, 'HP:0034245', 'Fetal head anomaly', 'MP:0000003', 'abnormal adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367443, 'HP:0008619', 'Bilateral sensorineural hearing impairment', 'MP:0006327', 'mixed hearing impairment', 0.4032258064516129, 12.464189314069232, 2.241848074230531, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(367444, 'HP:0008619', 'Bilateral sensorineural hearing impairment', 'MP:0006330', 'syndromic hearing impairment', 0.4032258064516129, 12.464189314069232, 2.241848074230531, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(367445, 'HP:0008619', 'Bilateral sensorineural hearing impairment', 'MP:0004699', 'unilateral deafness', 0.4032258064516129, 12.464189314069232, 2.241848074230531, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(367446, 'HP:0008619', 'Bilateral sensorineural hearing impairment', 'MP:0006329', 'sensorineural hearing impairment', 0.4032258064516129, 12.464189314069232, 2.241848074230531, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(367447, 'HP:0008619', 'Bilateral sensorineural hearing impairment', 'MP:0006326', 'conductive hearing impairment', 0.4032258064516129, 12.464189314069232, 2.241848074230531, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(367448, 'HP:0008619', 'Bilateral sensorineural hearing impairment', 'MP:0006328', 'nonsyndromic hearing impairment', 0.4032258064516129, 12.464189314069232, 2.241848074230531, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(367449, 'HP:0008619', 'Bilateral sensorineural hearing impairment', 'MP:0006325', 'impaired hearing', 0.4098360655737705, 12.464189314069232, 2.2601491784934833, 'UPHENO:0005518', 'decreased sensory perception of sound'),
(367450, 'HP:0001621', 'Weak voice', 'MP:0002106', 'abnormal muscle physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367451, 'HP:0001621', 'Weak voice', 'MP:0002164', 'abnormal gland physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367452, 'HP:0001621', 'Weak voice', 'MP:0031099', 'abnormal sputum morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367453, 'HP:0001621', 'Weak voice', 'MP:0014065', 'Lewy bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367454, 'HP:0001621', 'Weak voice', 'MP:0011203', 'abnormal parietal yolk sac morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367455, 'HP:0001621', 'Weak voice', 'MP:0001726', 'abnormal allantois morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367456, 'HP:0001621', 'Weak voice', 'MP:0013258', 'abnormal extracellular matrix morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367457, 'HP:0001621', 'Weak voice', 'MP:0002212', 'abnormal secondary sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367458, 'HP:0001621', 'Weak voice', 'MP:0006279', 'abnormal limb development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367459, 'HP:0001621', 'Weak voice', 'MP:0000767', 'abnormal smooth muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367460, 'HP:0001621', 'Weak voice', 'MP:0010425', 'abnormal heart and great vessel attachment', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367461, 'HP:0001621', 'Weak voice', 'MP:0005422', 'osteosclerosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367462, 'HP:0001621', 'Weak voice', 'MP:0001725', 'abnormal umbilical cord morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367463, 'HP:0001621', 'Weak voice', 'MP:0005502', 'abnormal renal/urinary system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367464, 'HP:0001621', 'Weak voice', 'MP:0031377', 'ambiguous external genitalia', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367465, 'HP:0001621', 'Weak voice', 'MP:0020982', 'abnormal skin adnexa development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367466, 'HP:0001621', 'Weak voice', 'MP:0001663', 'abnormal digestive system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367467, 'HP:0001621', 'Weak voice', 'MP:0000759', 'abnormal skeletal muscle morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367468, 'HP:0001621', 'Weak voice', 'MP:0014064', 'argyrophilic inclusion bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367469, 'HP:0001621', 'Weak voice', 'MP:0013083', 'tail wound', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367470, 'HP:0001621', 'Weak voice', 'MP:0010942', 'abnormal respiratory epithelium morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367471, 'HP:0001621', 'Weak voice', 'MP:0010820', 'abnormal pleura morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367472, 'HP:0001621', 'Weak voice', 'MP:0012058', 'abnormal morula morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367473, 'HP:0001621', 'Weak voice', 'MP:0003385', 'abnormal body wall morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367474, 'HP:0001621', 'Weak voice', 'MP:0031272', 'abnormal susceptibility to induced aneurysm formation', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367475, 'HP:0001621', 'Weak voice', 'MP:0006280', 'abnormal digit development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367476, 'HP:0001621', 'Weak voice', 'MP:0003935', 'abnormal craniofacial development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367477, 'HP:0001621', 'Weak voice', 'MP:0020370', 'abnormal glymphatic system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367478, 'HP:0001621', 'Weak voice', 'MP:0002086', 'abnormal extraembryonic tissue morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367479, 'HP:0001621', 'Weak voice', 'MP:0014062', 'nervous system inclusion bodies', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367480, 'HP:0001621', 'Weak voice', 'MP:0031092', 'dysgeusia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367481, 'HP:0001621', 'Weak voice', 'MP:0030222', 'hyperostosis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367482, 'HP:0001621', 'Weak voice', 'MP:0005652', 'sex reversal', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367483, 'HP:0001621', 'Weak voice', 'MP:0003942', 'abnormal urinary system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367484, 'HP:0001621', 'Weak voice', 'MP:0014066', 'Rosenthal fibers', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367485, 'HP:0001621', 'Weak voice', 'MP:0011186', 'abnormal visceral endoderm morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367486, 'HP:0001621', 'Weak voice', 'MP:0004134', 'abnormal chest morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367487, 'HP:0001621', 'Weak voice', 'MP:0001944', 'abnormal pancreas morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367488, 'HP:0001621', 'Weak voice', 'MP:0004957', 'abnormal blastocyst morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367489, 'HP:0001621', 'Weak voice', 'MP:0001919', 'abnormal reproductive system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367490, 'HP:0001621', 'Weak voice', 'MP:0010352', 'gastrointestinal tract polyps', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367491, 'HP:0001621', 'Weak voice', 'MP:0012684', 'abnormal pleural cavity morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367492, 'HP:0001621', 'Weak voice', 'MP:0013123', 'head/neck swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367493, 'HP:0001621', 'Weak voice', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367494, 'HP:0001621', 'Weak voice', 'MP:0010122', 'abnormal bone mineral content', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367495, 'HP:0001621', 'Weak voice', 'MP:0003115', 'abnormal respiratory system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367496, 'HP:0001621', 'Weak voice', 'MP:0030485', 'abnormal osteocyte lacunocanalicular system morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367497, 'HP:0001621', 'Weak voice', 'MP:0031274', 'increased susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367498, 'HP:0001621', 'Weak voice', 'MP:0008932', 'abnormal embryonic tissue physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367499, 'HP:0001621', 'Weak voice', 'MP:0004996', 'abnormal CNS synapse formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367500, 'HP:0001621', 'Weak voice', 'MP:0010678', 'abnormal skin adnexa morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367501, 'HP:0001621', 'Weak voice', 'MP:0000428', 'abnormal craniofacial morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367502, 'HP:0001621', 'Weak voice', 'MP:0000752', 'dystrophic muscle', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367503, 'HP:0001621', 'Weak voice', 'MP:0002109', 'abnormal limb morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367504, 'HP:0001621', 'Weak voice', 'MP:0003384', 'abnormal ventral body wall morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367505, 'HP:0001621', 'Weak voice', 'MP:0010478', 'intracranial aneurysm', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367506, 'HP:0001621', 'Weak voice', 'MP:0030572', 'abnormal pilosebaceous unit morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367507, 'HP:0001621', 'Weak voice', 'MP:0005621', 'abnormal cell physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367508, 'HP:0001621', 'Weak voice', 'MP:0013113', 'greasy tail', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367509, 'HP:0001621', 'Weak voice', 'MP:0003705', 'abnormal hypodermis morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367510, 'HP:0001621', 'Weak voice', 'MP:0005499', 'abnormal olfactory system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367511, 'HP:0001621', 'Weak voice', 'MP:0013332', 'peliosis', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367512, 'HP:0001621', 'Weak voice', 'MP:0001984', 'abnormal olfaction', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367513, 'HP:0001621', 'Weak voice', 'MP:0020515', 'abnormal visceral yolk sac endoderm morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367514, 'HP:0001621', 'Weak voice', 'MP:0001156', 'abnormal spermatogenesis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367515, 'HP:0001621', 'Weak voice', 'MP:0031277', 'pectus carinatum', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367516, 'HP:0001621', 'Weak voice', 'MP:0031310', 'abnormal cyst', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367517, 'HP:0001621', 'Weak voice', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367518, 'HP:0001621', 'Weak voice', 'MP:0000462', 'abnormal digestive system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367519, 'HP:0001621', 'Weak voice', 'MP:0000358', 'abnormal cell morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367520, 'HP:0001621', 'Weak voice', 'MP:0000733', 'abnormal muscle development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367521, 'HP:0001621', 'Weak voice', 'MP:0010680', 'abnormal skin adnexa physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367522, 'HP:0001621', 'Weak voice', 'MP:0004076', 'abnormal vitelline vascular remodeling', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367523, 'HP:0001621', 'Weak voice', 'MP:0000731', 'increased collagen deposition in the muscles', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367524, 'HP:0001621', 'Weak voice', 'MP:0011167', 'abnormal adipose tissue development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367525, 'HP:0001621', 'Weak voice', 'MP:0001790', 'abnormal immune system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367526, 'HP:0001621', 'Weak voice', 'MP:0010126', 'abnormal distal visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367527, 'HP:0001621', 'Weak voice', 'MP:0003890', 'abnormal embryonic-extraembryonic boundary morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367528, 'HP:0001621', 'Weak voice', 'MP:0003632', 'abnormal nervous system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367529, 'HP:0001621', 'Weak voice', 'MP:0002210', 'abnormal sex determination', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367530, 'HP:0001621', 'Weak voice', 'MP:0003861', 'abnormal nervous system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367531, 'HP:0001621', 'Weak voice', 'MP:0013121', 'testicular swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367532, 'HP:0001621', 'Weak voice', 'MP:0002111', 'abnormal tail morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367533, 'HP:0001621', 'Weak voice', 'MP:0002184', 'abnormal innervation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367534, 'HP:0001621', 'Weak voice', 'MP:0013119', 'abdomen swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367535, 'HP:0001621', 'Weak voice', 'MP:0004557', 'dilated allantois', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367536, 'HP:0001621', 'Weak voice', 'MP:0002211', 'abnormal primary sex determination', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367537, 'HP:0001621', 'Weak voice', 'MP:0001890', 'anencephaly', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367538, 'HP:0001621', 'Weak voice', 'MP:0010435', 'abnormal heart atrium and ventricle connection', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367539, 'HP:0001621', 'Weak voice', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367540, 'HP:0001621', 'Weak voice', 'MP:0012260', 'encephalomeningocele', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367541, 'HP:0001621', 'Weak voice', 'MP:0002113', 'abnormal skeleton development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367542, 'HP:0001621', 'Weak voice', 'MP:0011174', 'lipodystrophy', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367543, 'HP:0001621', 'Weak voice', 'MP:0013124', 'mouth swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367544, 'HP:0001621', 'Weak voice', 'MP:0002837', 'dystrophic cardiac calcinosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367545, 'HP:0001621', 'Weak voice', 'MP:0008493', 'alpha-synuclein inclusion body', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367546, 'HP:0001621', 'Weak voice', 'MP:0005334', 'abnormal fat pad morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367547, 'HP:0001621', 'Weak voice', 'MP:0001983', 'abnormal olfactory system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367548, 'HP:0001621', 'Weak voice', 'MP:0001986', 'abnormal taste sensitivity', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367549, 'HP:0001621', 'Weak voice', 'MP:0010736', 'abnormal extraembryonic ectoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367550, 'HP:0001621', 'Weak voice', 'MP:0002932', 'abnormal joint morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367551, 'HP:0001621', 'Weak voice', 'MP:0013177', 'abnormal tail tip morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367552, 'HP:0001621', 'Weak voice', 'MP:0014063', 'Lafora bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367553, 'HP:0001621', 'Weak voice', 'MP:0005360', 'urolithiasis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367554, 'HP:0001621', 'Weak voice', 'MP:0011200', 'abnormal extraembryonic coelom morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367555, 'HP:0001621', 'Weak voice', 'MP:0014137', 'abnormal preimplantation embryo morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367556, 'HP:0001621', 'Weak voice', 'MP:0000467', 'abnormal esophagus morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367557, 'HP:0001621', 'Weak voice', 'MP:0000736', 'delayed muscle development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367558, 'HP:0001621', 'Weak voice', 'MP:0008923', 'thoracoschisis', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367559, 'HP:0001621', 'Weak voice', 'MP:0020973', 'abnormal gland development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367560, 'HP:0001621', 'Weak voice', 'MP:0003301', 'peptic ulcer', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367561, 'HP:0001621', 'Weak voice', 'MP:0002970', 'abnormal white adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367562, 'HP:0001621', 'Weak voice', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367563, 'HP:0001621', 'Weak voice', 'MP:0009250', 'abnormal appendicular skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367564, 'HP:0001621', 'Weak voice', 'MP:0002085', 'abnormal embryonic tissue morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367565, 'HP:0001621', 'Weak voice', 'MP:0005504', 'abnormal ligament morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367566, 'HP:0001621', 'Weak voice', 'MP:0003279', 'aneurysm', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367567, 'HP:0001621', 'Weak voice', 'MP:0000572', 'abnormal autopod morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367568, 'HP:0001621', 'Weak voice', 'MP:0012070', 'abnormal susceptibility to osteoporosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367569, 'HP:0001621', 'Weak voice', 'MP:0004179', 'transmission ratio distortion', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367570, 'HP:0001621', 'Weak voice', 'MP:0002163', 'abnormal gland morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367571, 'HP:0001621', 'Weak voice', 'MP:0000003', 'abnormal adipose tissue morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367572, 'HP:0001621', 'Weak voice', 'MP:0011199', 'abnormal amniotic cavity morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367573, 'HP:0001621', 'Weak voice', 'MP:0002139', 'abnormal hepatobiliary system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367574, 'HP:0001621', 'Weak voice', 'MP:0000516', 'abnormal renal/urinary system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367575, 'HP:0001621', 'Weak voice', 'MP:0014136', 'abnormal extraembryonic endoderm morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367576, 'HP:0001621', 'Weak voice', 'MP:0002060', 'abnormal skin morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367577, 'HP:0001621', 'Weak voice', 'MP:0000550', 'abnormal forelimb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367578, 'HP:0001621', 'Weak voice', 'MP:0031100', 'hemoptysis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367579, 'HP:0001621', 'Weak voice', 'MP:0002399', 'abnormal pluripotent precursor cell morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367580, 'HP:0001621', 'Weak voice', 'MP:0000685', 'abnormal immune system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367581, 'HP:0001621', 'Weak voice', 'MP:0011487', 'abnormal ureteropelvic junction morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367582, 'HP:0001621', 'Weak voice', 'MP:0012685', 'abnormal primitive streak elongation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367583, 'HP:0001621', 'Weak voice', 'MP:0005500', 'abnormal gustatory system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367584, 'HP:0001621', 'Weak voice', 'MP:0020452', 'abnormal axon radial sorting', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367585, 'HP:0001621', 'Weak voice', 'MP:0002114', 'abnormal axial skeleton morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367586, 'HP:0001621', 'Weak voice', 'MP:0013558', 'abnormal exocrine gland morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367587, 'HP:0001621', 'Weak voice', 'MP:0003633', 'abnormal nervous system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367588, 'HP:0001621', 'Weak voice', 'MP:0011488', 'abnormal ureterovesical junction morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367589, 'HP:0001621', 'Weak voice', 'MP:0001722', 'pale yolk sac', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367590, 'HP:0001621', 'Weak voice', 'MP:0006281', 'abnormal tail development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367591, 'HP:0001621', 'Weak voice', 'MP:0005459', 'decreased percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367592, 'HP:0001621', 'Weak voice', 'MP:0005458', 'increased percent body fat/body weight', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367593, 'HP:0001621', 'Weak voice', 'MP:0001718', 'abnormal visceral yolk sac morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367594, 'HP:0001621', 'Weak voice', 'MP:0013126', 'teat swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367595, 'HP:0001621', 'Weak voice', 'MP:0002133', 'abnormal respiratory system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367596, 'HP:0001621', 'Weak voice', 'MP:0001985', 'abnormal gustatory system physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367597, 'HP:0001621', 'Weak voice', 'MP:0013120', 'urogenital swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367598, 'HP:0001621', 'Weak voice', 'MP:0014134', 'abnormal embryo morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367599, 'HP:0001621', 'Weak voice', 'MP:0013125', 'thorax swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367600, 'HP:0001621', 'Weak voice', 'MP:0002653', 'abnormal ependyma morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367601, 'HP:0001621', 'Weak voice', 'MP:0013122', 'tail swellings', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367602, 'HP:0001621', 'Weak voice', 'MP:0002836', 'abnormal chorion morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367603, 'HP:0001621', 'Weak voice', 'MP:0001175', 'abnormal lung morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367604, 'HP:0001621', 'Weak voice', 'MP:0001929', 'abnormal gametogenesis', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367605, 'HP:0001621', 'Weak voice', 'MP:0010233', 'hairless tail', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367606, 'HP:0001621', 'Weak voice', 'MP:0001533', 'abnormal skeleton physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367607, 'HP:0001621', 'Weak voice', 'MP:0003936', 'abnormal reproductive system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367608, 'HP:0001621', 'Weak voice', 'MP:0010874', 'abnormal bone volume', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367609, 'HP:0001621', 'Weak voice', 'MP:0012531', 'delayed limb development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367610, 'HP:0001621', 'Weak voice', 'MP:0000266', 'abnormal heart morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367611, 'HP:0001621', 'Weak voice', 'MP:0008533', 'abnormal anterior visceral endoderm morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367612, 'HP:0001621', 'Weak voice', 'MP:0001724', 'abnormal extraembryonic endoderm formation', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367613, 'HP:0001621', 'Weak voice', 'MP:0005508', 'abnormal skeleton morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367614, 'HP:0001621', 'Weak voice', 'MP:0013118', 'swellings', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367615, 'HP:0001621', 'Weak voice', 'MP:0013133', 'pale limbs', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367616, 'HP:0001621', 'Weak voice', 'MP:0002127', 'abnormal cardiovascular system morphology', 0.47368421052631576, 1.7901636446558942, 0.9208540887305324, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367617, 'HP:0001621', 'Weak voice', 'MP:0002925', 'abnormal cardiovascular development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367618, 'HP:0001621', 'Weak voice', 'MP:0012500', 'abnormal angioblastic cord morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367619, 'HP:0001621', 'Weak voice', 'MP:0031273', 'decreased susceptibility to induced aneurysm formation', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367620, 'HP:0001621', 'Weak voice', 'MP:0002132', 'abnormal respiratory system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367621, 'HP:0001621', 'Weak voice', 'MP:0000566', 'synostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367622, 'HP:0001621', 'Weak voice', 'MP:0013283', 'failure of ventral body wall closure', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367623, 'HP:0001621', 'Weak voice', 'MP:0020516', 'abnormal visceral yolk sac mesenchyme morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367624, 'HP:0001621', 'Weak voice', 'MP:0003119', 'abnormal digestive system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367625, 'HP:0001621', 'Weak voice', 'MP:0000427', 'abnormal hair cycle', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367626, 'HP:0001621', 'Weak voice', 'MP:0003795', 'abnormal bone structure', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367627, 'HP:0001621', 'Weak voice', 'MP:0009877', 'exostosis', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367628, 'HP:0001621', 'Weak voice', 'MP:0031348', 'bone fibrous dysplasia', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367629, 'HP:0001621', 'Weak voice', 'MP:0000556', 'abnormal hindlimb morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367630, 'HP:0001621', 'Weak voice', 'MP:0002971', 'abnormal brown adipose tissue morphology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367631, 'HP:0001621', 'Weak voice', 'MP:0004558', 'delayed allantois development', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367632, 'HP:0001621', 'Weak voice', 'MP:0020981', 'abnormal immune system development', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367633, 'HP:0001621', 'Weak voice', 'MP:0001545', 'abnormal hematopoietic system physiology', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367634, 'HP:0001621', 'Weak voice', 'MP:0002396', 'abnormal hematopoietic system morphology/development', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367635, 'HP:0001621', 'Weak voice', 'MP:0002108', 'abnormal muscle morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367636, 'HP:0001621', 'Weak voice', 'MP:0014067', 'Hirano bodies', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367637, 'HP:0001621', 'Weak voice', 'MP:0002160', 'abnormal reproductive system morphology', 0.45, 1.7901636446558942, 0.8975375424432965, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367638, 'HP:0001621', 'Weak voice', 'MP:0005029', 'abnormal amnion morphology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367639, 'HP:0001621', 'Weak voice', 'MP:0004264', 'abnormal extraembryonic tissue physiology', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367640, 'HP:0001621', 'Weak voice', 'MP:0003300', 'gastrointestinal ulcer', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367641, 'HP:0001621', 'Weak voice', 'MP:0013304', 'osteophytes', 0.4090909090909091, 1.7901636446558942, 0.8557684691631112, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367642, 'HP:0001621', 'Weak voice', 'MP:0005457', 'abnormal percent body fat/body weight', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367643, 'HP:0001621', 'Weak voice', 'MP:0012514', 'pectus excavatum', 0.42857142857142855, 1.7901636446558942, 0.8759069531444602, 'UPHENO:0002536', 'abnormal anatomical entity'),
(367644, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0012176', 'abnormal head development', 0.4375, 4.6730878730104815, 1.4298517211382744, 'UPHENO:0087907', 'abnormal head morphology'),
(367645, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0000020', 'scaly ears', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(367646, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0020290', 'floppy ears', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(367647, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0002102', 'abnormal ear morphology', 0.48484848484848486, 7.8051695233081215, 1.9453340631782279, 'UPHENO:0076730', 'abnormal ear morphology'),
(367648, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030226', 'middle ear polyps', 0.4722222222222222, 9.948935785159481, 2.1675120680665656, 'UPHENO:0003017', 'abnormal middle ear'),
(367649, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030324', 'abnormal anterior head development', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(367650, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030161', 'absent auditory bulla', 0.45714285714285713, 7.8051695233081215, 1.888935545848356, 'UPHENO:0076730', 'abnormal ear morphology'),
(367651, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0000035', 'abnormal membranous labyrinth morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(367652, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030413', 'tympanic membrane retraction', 0.4358974358974359, 9.948935785159481, 2.0824782348584727, 'UPHENO:0003017', 'abnormal middle ear'),
(367653, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0000026', 'abnormal inner ear morphology', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(367654, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030321', 'abnormal tegmen tympani morphology', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(367655, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0003677', 'abnormal ear lobe morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(367656, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0002177', 'abnormal outer ear morphology', 0.4444444444444444, 7.8051695233081215, 1.862515565728616, 'UPHENO:0076730', 'abnormal ear morphology'),
(367657, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030160', 'abnormal auditory bulla morphology', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(367658, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0002729', 'abnormal inner ear canal morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(367659, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0002859', 'abnormal inner ear canal fusion', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(367660, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0000432', 'abnormal head morphology', 0.45161290322580644, 4.6730878730104815, 1.4527308014080145, 'UPHENO:0087907', 'abnormal head morphology'),
(367661, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0000428', 'abnormal craniofacial morphology', 0.41379310344827586, 4.656469875639396, 1.3880976626139216, 'UPHENO:0086589', 'abnormal craniocervical region morphology'),
(367662, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030092', 'abnormal outer ear helix morphology', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(367663, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0020900', 'abnormal middle ear epithelium morphology', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(367664, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030228', 'absent tubotympanic recess', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(367665, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030227', 'abnormal tubotympanic recess morphology', 0.4722222222222222, 9.948935785159481, 2.1675120680665656, 'UPHENO:0003017', 'abnormal middle ear'),
(367666, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0013097', 'ear wound', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(367667, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0003682', 'linear crease in ear lobe', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(367668, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0006033', 'abnormal external auditory canal morphology', 0.41025641025641024, 7.8051695233081215, 1.7894470738401644, 'UPHENO:0076730', 'abnormal ear morphology'),
(367669, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0011238', 'abnormal inner ear development', 0.42105263157894735, 7.8051695233081215, 1.8128395317039736, 'UPHENO:0076730', 'abnormal ear morphology'),
(367670, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0006018', 'abnormal tympanic membrane morphology', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(367671, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0003938', 'abnormal ear development', 0.47058823529411764, 7.8051695233081215, 1.9165127059701426, 'UPHENO:0076730', 'abnormal ear morphology'),
(367672, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0003330', 'abnormal auditory tube morphology', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(367673, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0000049', 'abnormal middle ear morphology', 0.4857142857142857, 9.948935785159481, 2.1982584558022364, 'UPHENO:0003017', 'abnormal middle ear'),
(367674, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030410', 'middle ear effusion', 0.40476190476190477, 9.948935785159481, 2.006726239115597, 'UPHENO:0003017', 'abnormal middle ear'),
(367675, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030187', 'abnormal epitympanic recess morphology', 0.4473684210526316, 9.948935785159481, 2.109701327999018, 'UPHENO:0003017', 'abnormal middle ear'),
(367676, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0003737', 'ossification of pinnae', 0.43243243243243246, 7.8051695233081215, 1.837174037077495, 'UPHENO:0076730', 'abnormal ear morphology'),
(367677, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0020304', 'abnormal horn morphology', 0.42424242424242425, 4.6730878730104815, 1.4080206418742023, 'UPHENO:0087907', 'abnormal head morphology'),
(367678, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0003743', 'abnormal facial morphology', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(367679, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030178', 'abnormal scalp morphology', 0.4117647058823529, 4.6730878730104815, 1.3871599235821914, 'UPHENO:0087907', 'abnormal head morphology'),
(367680, 'HP:0040118', 'Stenosis of the Eustachian tube', 'MP:0030154', 'abnormal tympanic cavity morphology', 0.4594594594594595, 9.948935785159481, 2.138020733773704, 'UPHENO:0003017', 'abnormal middle ear'),
(367681, 'HP:0005247', 'Hypoplasia of the abdominal wall musculature', 'MP:0000734', 'muscle hypoplasia', 0.48936170212765956, 12.700256672302759, 2.492994027793938, 'UPHENO:0081082', 'muscle organ hypoplasia'),
(367682, 'HP:0005247', 'Hypoplasia of the abdominal wall musculature', 'MP:0009460', 'skeletal muscle hypoplasia', 0.40350877192982454, 12.700256672302759, 2.263772288246865, 'UPHENO:0081082', 'muscle organ hypoplasia'),
(367683, 'HP:0005247', 'Hypoplasia of the abdominal wall musculature', 'MP:0003359', 'hypaxial muscle hypoplasia', 0.42592592592592593, 12.700256672302759, 2.325804932200349, 'UPHENO:0081082', 'muscle organ hypoplasia'),
(367684, 'HP:0032250', 'Acinetobacter infection', 'MP:0004829', 'increased anti-chromatin antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367685, 'HP:0032250', 'Acinetobacter infection', 'MP:0004149', 'increased bone strength', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367686, 'HP:0032250', 'Acinetobacter infection', 'MP:0008564', 'increased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367687, 'HP:0032250', 'Acinetobacter infection', 'MP:0004762', 'increased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367688, 'HP:0032250', 'Acinetobacter infection', 'MP:0014275', 'increased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367689, 'HP:0032250', 'Acinetobacter infection', 'MP:0000316', 'cellular necrosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367690, 'HP:0032250', 'Acinetobacter infection', 'MP:0008712', 'decreased interleukin-9 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367691, 'HP:0032250', 'Acinetobacter infection', 'MP:0030132', 'periodontium inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367692, 'HP:0032250', 'Acinetobacter infection', 'MP:0020848', 'abnormal exocytosis', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367693, 'HP:0032250', 'Acinetobacter infection', 'MP:0008701', 'abnormal interleukin-5 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367694, 'HP:0032250', 'Acinetobacter infection', 'MP:0008746', 'abnormal peripheral B cell anergy', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367695, 'HP:0032250', 'Acinetobacter infection', 'MP:0020163', 'increased susceptibility to virus induced diabetes', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367696, 'HP:0032250', 'Acinetobacter infection', 'MP:0031091', 'hypogeusia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367697, 'HP:0032250', 'Acinetobacter infection', 'MP:0010994', 'aerophagia', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367698, 'HP:0032250', 'Acinetobacter infection', 'MP:0003674', 'oxidative stress', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367699, 'HP:0032250', 'Acinetobacter infection', 'MP:0001194', 'dermatitis', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367700, 'HP:0032250', 'Acinetobacter infection', 'MP:0008689', 'abnormal interleukin-23 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367701, 'HP:0032250', 'Acinetobacter infection', 'MP:0008657', 'increased interleukin-1 beta secretion', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367702, 'HP:0032250', 'Acinetobacter infection', 'MP:0003091', 'abnormal cell migration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367703, 'HP:0032250', 'Acinetobacter infection', 'MP:0006323', 'abnormal extraembryonic mesoderm development', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367704, 'HP:0032250', 'Acinetobacter infection', 'MP:0030153', 'dental pulp inflammation', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367705, 'HP:0032250', 'Acinetobacter infection', 'MP:0031066', 'cytokine storm', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367706, 'HP:0032250', 'Acinetobacter infection', 'MP:0010753', 'improved mucociliary clearance', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367707, 'HP:0032250', 'Acinetobacter infection', 'MP:0012556', 'increased cell death', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367708, 'HP:0032250', 'Acinetobacter infection', 'MP:0001943', 'abnormal respiration', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367709, 'HP:0032250', 'Acinetobacter infection', 'MP:0008197', 'abnormal follicular dendritic cell physiology', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367710, 'HP:0032250', 'Acinetobacter infection', 'MP:0004804', 'decreased susceptibility to autoimmune diabetes', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367711, 'HP:0032250', 'Acinetobacter infection', 'MP:0006114', 'cardiac murmur', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367712, 'HP:0032250', 'Acinetobacter infection', 'MP:0004821', 'increased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367713, 'HP:0032250', 'Acinetobacter infection', 'MP:0010559', 'heart block', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367714, 'HP:0032250', 'Acinetobacter infection', 'MP:0003477', 'abnormal nerve fiber response', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367715, 'HP:0032250', 'Acinetobacter infection', 'MP:0008660', 'increased interleukin-10 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367716, 'HP:0032250', 'Acinetobacter infection', 'MP:0003868', 'abnormal feces composition', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367717, 'HP:0032250', 'Acinetobacter infection', 'MP:0008710', 'abnormal interleukin-9 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367718, 'HP:0032250', 'Acinetobacter infection', 'MP:0010755', 'abnormal heart right ventricle pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367719, 'HP:0032250', 'Acinetobacter infection', 'MP:0011399', 'increased endoneurial fluid pressure', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367720, 'HP:0032250', 'Acinetobacter infection', 'MP:0020918', 'abnormal susceptibility to Ortervirales infection', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367721, 'HP:0032250', 'Acinetobacter infection', 'MP:0004798', 'decreased anti-double stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367722, 'HP:0032250', 'Acinetobacter infection', 'MP:0013559', 'abnormal exocrine gland physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367723, 'HP:0032250', 'Acinetobacter infection', 'MP:0004771', 'increased anti-single stranded DNA antibody level', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367724, 'HP:0032250', 'Acinetobacter infection', 'MP:0013498', 'trachea inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367725, 'HP:0032250', 'Acinetobacter infection', 'MP:0008698', 'abnormal interleukin-4 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367726, 'HP:0032250', 'Acinetobacter infection', 'MP:0031098', 'abnormal sputum production', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367727, 'HP:0032250', 'Acinetobacter infection', 'MP:0004782', 'abnormal surfactant physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367728, 'HP:0032250', 'Acinetobacter infection', 'MP:0030987', 'spinal cord inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367729, 'HP:0032250', 'Acinetobacter infection', 'MP:0004045', 'abnormal cell cycle checkpoint function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367730, 'HP:0032250', 'Acinetobacter infection', 'MP:0001793', 'abnormal susceptibility to infection', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367731, 'HP:0032250', 'Acinetobacter infection', 'MP:0020187', 'abnormal susceptibility to prion infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367732, 'HP:0032250', 'Acinetobacter infection', 'MP:0005666', 'abnormal adipose tissue physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367733, 'HP:0032250', 'Acinetobacter infection', 'MP:0002693', 'abnormal pancreas physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367734, 'HP:0032250', 'Acinetobacter infection', 'MP:0003621', 'dysuria', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367735, 'HP:0032250', 'Acinetobacter infection', 'MP:0008702', 'increased interleukin-5 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367736, 'HP:0032250', 'Acinetobacter infection', 'MP:0012028', 'abnormal visceral endoderm physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367737, 'HP:0032250', 'Acinetobacter infection', 'MP:0021014', 'abnormal tau protein phosphorylation', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367738, 'HP:0032250', 'Acinetobacter infection', 'MP:0008566', 'increased interferon-gamma secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367739, 'HP:0032250', 'Acinetobacter infection', 'MP:0011043', 'abnormal lung elastance', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367740, 'HP:0032250', 'Acinetobacter infection', 'MP:0002410', 'decreased susceptibility to viral infection', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367741, 'HP:0032250', 'Acinetobacter infection', 'MP:0004947', 'skin inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367742, 'HP:0032250', 'Acinetobacter infection', 'MP:0008737', 'abnormal spleen physiology', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367743, 'HP:0032250', 'Acinetobacter infection', 'MP:0001983', 'abnormal olfactory system physiology', 0.46153846153846156, 5.059610039003922, 1.52813763561612, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367744, 'HP:0032250', 'Acinetobacter infection', 'MP:0001846', 'increased inflammatory response', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367745, 'HP:0032250', 'Acinetobacter infection', 'MP:0012186', 'abnormal muscle precursor cell physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367746, 'HP:0032250', 'Acinetobacter infection', 'MP:0031221', 'abnormal CXCL10 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367747, 'HP:0032250', 'Acinetobacter infection', 'MP:0021052', 'abnormal renal arterial blood pressure regulation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367748, 'HP:0032250', 'Acinetobacter infection', 'MP:0009056', 'abnormal interleukin-21 secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367749, 'HP:0032250', 'Acinetobacter infection', 'MP:0004801', 'increased susceptibility to systemic lupus erythematosus', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367750, 'HP:0032250', 'Acinetobacter infection', 'MP:0031302', 'syncope', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367751, 'HP:0032250', 'Acinetobacter infection', 'MP:0004795', 'decreased anti-nuclear antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367752, 'HP:0032250', 'Acinetobacter infection', 'MP:0008722', 'abnormal chemokine secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367753, 'HP:0032250', 'Acinetobacter infection', 'MP:0002473', 'impaired complement classical pathway', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367754, 'HP:0032250', 'Acinetobacter infection', 'MP:0020093', 'decreased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367755, 'HP:0032250', 'Acinetobacter infection', 'MP:0001544', 'abnormal cardiovascular system physiology', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367756, 'HP:0032250', 'Acinetobacter infection', 'MP:0008560', 'increased tumor necrosis factor secretion', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367757, 'HP:0032250', 'Acinetobacter infection', 'MP:0004797', 'increased anti-erythrocyte antigen antibody level', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367758, 'HP:0032250', 'Acinetobacter infection', 'MP:0008663', 'increased interleukin-12 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367759, 'HP:0032250', 'Acinetobacter infection', 'MP:0001861', 'lung inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367760, 'HP:0032250', 'Acinetobacter infection', 'MP:0005673', 'decreased susceptibility to graft versus host disease', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367761, 'HP:0032250', 'Acinetobacter infection', 'MP:0031125', 'aspiration pneumonia', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367762, 'HP:0032250', 'Acinetobacter infection', 'MP:0030924', 'early exit from telogen phase', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367763, 'HP:0032250', 'Acinetobacter infection', 'MP:0001873', 'stomach inflammation', 0.4375, 7.400946880077414, 1.7994205345148946, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367764, 'HP:0032250', 'Acinetobacter infection', 'MP:0003880', 'abnormal central pattern generator function', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367765, 'HP:0032250', 'Acinetobacter infection', 'MP:0011764', 'ureteritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367766, 'HP:0032250', 'Acinetobacter infection', 'MP:0012566', 'decreased susceptibility to experimental autoimmune orchitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367767, 'HP:0032250', 'Acinetobacter infection', 'MP:0012196', 'abnormal myofibroblast differentiation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367768, 'HP:0032250', 'Acinetobacter infection', 'MP:0020185', 'abnormal susceptibility to viral infection', 0.4827586206896552, 7.400946880077414, 1.8902039328134885, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367769, 'HP:0032250', 'Acinetobacter infection', 'MP:0004037', 'increased muscle relaxation', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367770, 'HP:0032250', 'Acinetobacter infection', 'MP:0004142', 'abnormal muscle tone', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367771, 'HP:0032250', 'Acinetobacter infection', 'MP:0002314', 'abnormal respiratory mechanics', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367772, 'HP:0032250', 'Acinetobacter infection', 'MP:0008651', 'increased interleukin-1 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367773, 'HP:0032250', 'Acinetobacter infection', 'MP:0008568', 'abnormal interleukin secretion', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367774, 'HP:0032250', 'Acinetobacter infection', 'MP:0012685', 'abnormal primitive streak elongation', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367775, 'HP:0032250', 'Acinetobacter infection', 'MP:0004822', 'decreased susceptibility to experimental autoimmune uveoretinitis', 0.45161290322580644, 7.400946880077414, 1.828213091281138, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367776, 'HP:0032250', 'Acinetobacter infection', 'MP:0002327', 'abnormal respiratory function', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367777, 'HP:0032250', 'Acinetobacter infection', 'MP:0008670', 'decreased interleukin-12b secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367778, 'HP:0032250', 'Acinetobacter infection', 'MP:0013475', 'delayed reproductive senescence', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367779, 'HP:0032250', 'Acinetobacter infection', 'MP:0031111', 'meningoencephalitis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367780, 'HP:0032250', 'Acinetobacter infection', 'MP:0020412', 'abnormal amnion physiology', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367781, 'HP:0032250', 'Acinetobacter infection', 'MP:0001866', 'nasal inflammation', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367782, 'HP:0032250', 'Acinetobacter infection', 'MP:0008565', 'decreased interferon-beta secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367783, 'HP:0032250', 'Acinetobacter infection', 'MP:0020094', 'increased susceptibility to aortic cartilaginous metaplasia', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367784, 'HP:0032250', 'Acinetobacter infection', 'MP:0011398', 'abnormal endoneurial fluid pressure', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367785, 'HP:0032250', 'Acinetobacter infection', 'MP:0000423', 'delayed hair regrowth', 0.42857142857142855, 5.059610039003922, 1.4725502716139276, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367786, 'HP:0032250', 'Acinetobacter infection', 'MP:0005615', 'increased susceptibility to type III hypersensitivity reaction', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367787, 'HP:0032250', 'Acinetobacter infection', 'MP:0001984', 'abnormal olfaction', 0.4444444444444444, 5.059610039003922, 1.4995717965108013, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367788, 'HP:0032250', 'Acinetobacter infection', 'MP:0010538', 'increased level of surface class II molecules', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367789, 'HP:0032250', 'Acinetobacter infection', 'MP:0014274', 'decreased respiration', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367790, 'HP:0032250', 'Acinetobacter infection', 'MP:0008735', 'increased susceptibility to endotoxin shock', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367791, 'HP:0032250', 'Acinetobacter infection', 'MP:0021024', 'abnormal cerebrospinal fluid physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367792, 'HP:0032250', 'Acinetobacter infection', 'MP:0008684', 'increased interleukin-18 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367793, 'HP:0032250', 'Acinetobacter infection', 'MP:0005044', 'sepsis', 0.5, 7.400946880077414, 1.923661467108677, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367794, 'HP:0032250', 'Acinetobacter infection', 'MP:0005025', 'abnormal response to infection', 0.5185185185185185, 7.400946880077414, 1.95896095211007, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367795, 'HP:0032250', 'Acinetobacter infection', 'MP:0008750', 'abnormal interferon level', 0.4117647058823529, 7.400946880077414, 1.745694336167129, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367796, 'HP:0032250', 'Acinetobacter infection', 'MP:0003878', 'abnormal ear physiology', 0.41379310344827586, 5.059610039003922, 1.4469387479356148, 'UPHENO:0002332', 'abnormality of anatomical entity physiology'),
(367797, 'HP:0032250', 'Acinetobacter infection', 'MP:0008687', 'increased interleukin-2 secretion', 0.4666666666666667, 7.400946880077414, 1.858433536799956, 'UPHENO:0002263', 'abnormality of immune system physiology'),
(367798, 'HP:0032250', 'Acinetobacter infection', 'MP:0031053', 'pleuritis', 0.42424242424242425, 7.400946880077414, 1.7719468519381298, 'UPHENO:0002263', 'abnormality of immune system physiology'),
